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Summary
Mammalian T lymphocytes are a prototype for development from adult pluripotent stem cells. While
T-cell specification is driven by Notch signaling, T-lineage commitment is only finalized after
prolonged Notch activation. However, no T-lineage specific regulatory factor has been reported that
mediates commitment. We used a gene-discovery approach to identify additional candidate T-lineage
transcription factors and characterized expression of >100 regulatory genes in early T-cell precursors
using realtime RT-PCR. These regulatory genes were also monitored in multilineage precursors as
they entered T-cell or non-T-cell pathways in vitro; in non-T cells ex vivo; and in later T-cell
developmental stages after lineage commitment. At least three major expression patterns were
observed. Transcription factors in the largest group are expressed at relatively stable levels
throughout T-lineage specification as a legacy from prethymic precursors, with some continuing
while others are downregulated after commitment. Another group is highly expressed in the earliest
stages only, and is downregulated before or during commitment. Genes in a third group undergo
upregulation at one of three distinct transitions, suggesting a positive regulatory cascade. However,
the transcription factors induced during commitment are not T-lineage specific. Different members
of the same transcription factor family can follow opposite trajectories during specification and
commitment, while factors co-expressed early can be expressed in divergent patterns in later T-cell
development. Some factors reveal new regulatory distinctions between αβ and γδ T-lineage
differentiation. These results show that T-cell identity has an essentially complex regulatory basis
and provide a detailed framework for regulatory network modeling of T-cell specification.
INTRODUCTION
T-cell development is an exceptionally favorable system in which to examine the mechanism
of differentiation from stem cells in general. It offers the most completely identified sequence
of developmental intermediates known for any post-embryonic stem-cell derivatives. Cells
with T-cell precursor activity become physically segregated from other blood-cell precursors
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by migrating to the thymus at a very early stage of their development (Shortman and Wu,
1996; Ceredig and Rolink, 2002; Petrie and Zuniga-Pflucker, 2007; Rothenberg et al., 2008).
This allows these intermediates to be purified for analysis with minimal interference from
irrelevant cell populations. Also, because individual T-cell precursors can be isolated relatively
easily, it has been possible to define the series of distinct steps at which particular
developmental alternatives are lost during the stages leading up to lineage commitment
(Rothenberg, 2007). T-lineage specification is both triggered and sustained by Notch signaling.
Yet the way lineage-specific gene expression actually starts and how T-lineage identity is
cemented at commitment are both questions still to be resolved.
T lymphocyte development from hematopoietic stem cells is not driven by a single “master
gene”, but rather depends upon a large number of distinct regulatory factors, as shown by
genetic evidence in targeted mutant mice (Anderson, 2006; Rothenberg and Taghon, 2005).
Notch pathway signaling, triggered by ligands in the thymic microenvironment, is a central
element, needed both to begin T-cell specification and to complete lineage commitment.
However, to promote T-lineage development this signal must act on cells that also have an
appropriate constellation of intrinsic regulatory activities. Among the transcription factors
already known to have critical roles are GATA-3, Myb, Runx1+CBFβ, Ikaros, TCF-1 activated
by Wnt, RBP-J activated by Notch, basic helix-loop-helix “E proteins”, Gfi1, and in an early
hit-and-run role, hematopoietic transcription factor PU.1. Most of these regulatory inputs are
needed to allow recognizable T-lineage precursors to emerge in the thymus from the earliest
stages, long before the cells express T-cell receptors for antigen and undergo selection events
that depend on those receptors. Most of the same factors are then used repeatedly over many
cell cycles for days or weeks to define T-cell subtypes (Rothenberg et al., 2008; Ho and Pai,
2007; Tanigaki and Honjo, 2007; Anderson, 2006; Rothenberg and Taghon, 2005; Staal et al.,
2001).
Although identities of these factors are clear, the transcriptional mechanisms that result in T-
cell specification have remained more obscure than those involved in specification of many
other hematopoietic cell types, especially as contrasted with another lymphoid cell type,
namely B lymphocytes (Rothenberg, 2007; Rothenberg and Taghon, 2005). B cell identity is
now known to be created through the action of a cascade of transcription factors in which key
roles are played by EBF and Pax5, two dedicated factors that are B-lineage specific in
expression as well as function within the hematopoietic system (Cobaleda et al., 2007; Singh
et al., 2007; Nutt and Kee, 2007; Hagman and Lukin, 2006). Because of their specific
expression patterns, mutations in these factors also yield selective defects in B-cell
development that can be staged and characterized in molecular terms. These factors also act
effectively as positive B-lineage regulators in both gain of function and loss of function
experiments. The result has been a definitive elucidation of the B-lineage specification process
(Cobaleda et al., 2007; Singh et al., 2007; Nutt and Kee, 2007; Hagman and Lukin, 2006).
There are indeed two well-studied factors that are T-lineage specific in expression, namely
GATA-3 and TCF-1 (product of the Tcf7 gene), and it has been known for years that these are
both required specifically for T-cell development (Verbeek et al., 1995; Ting et al., 1996;
Hattori et al., 1996). However, in marked contrast to the B-cell factors, these do not appear to
upregulate T-lineage target genes specifically and do not enhance T-cell development in gain
of function experiments (Taghon et al., 2007; Kirstetter et al., 2006; Scheller et al., 2006; Baba
et al., 2005; Staal et al., 2004; Anderson et al., 2002a). One possible interpretation of existing
data is that T-lineage choice is fundamentally different from B lineage choice; but another
possibility has been that the EBF and Pax5 equivalents for T cells simply have yet to be
recognized. Therefore, a crucial question is whether other transcription factors may exist in
early T-lineage cells that could play more cell-type specific roles.
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This study and its predecessors (Tydell et al., 2007; Anderson et al., 1999) were undertaken to
identify any “missing” regulators of T-cell development that may be T-cell lineage specific,
to track the major changes in transcription factors generally as cells progress toward T-lineage
commitment, and to clarify how their roles and expression are coordinated with the observed
landmarks in T-cell development (Rothenberg et al., 2008). In this study, we have relied on
cDNA macroarray screening for gene discovery and on sensitive, quantitative realtime RT-
PCR (qPCR) measurements to identify a large group of regulatory gene candidates and track
the way that they and their family members are expressed in early T-lineage precursors. The
results show that the T-cell specification process entails discontinuous upregulation of one
group of transcription factor genes, surprisingly stable expression of a larger group of stem
cell-inherited factors until after commitment, and downregulation of another substantial group
of previously expressed transcription factor genes. However, few regulatory genes overall have
highly specific T-cell expression, and while T-lineage commitment also causes upregulation
of certain transcription factor genes, most of these are not T-lineage specific. These results add
substantial detail to the transcription factor dynamics that underlie T-cell specification and
strengthen the probability that there is a fundamental divergence between the overall regulatory
strategies involved in T-cell and B-cell lineage choice.
MATERIALS AND METHODS
Animals
Cells were obtained from C57BL/6 mice and from mice of TCRβ−/− and Rag2−/− genotypes
on a C57BL/6 background, all maintained in our breeding colony at the California Institute of
Technology (Caltech). “Adult” samples were from 4–6 week old mice for thymocyte isolation
and from 8–12 week old mice for bone marrow isolation. Fetal liver was obtained from timed
pregnancies of C57BL/6 or (C57BL/6 × DBA/2) F1 mice at E14.5 (day of plug = E0.5). Animals
were kept in microisolator cages in an AAALAC-accredited facility with the immune-deficient
mutants maintained with sterilized cages, water, food, and bedding. Euthanasia and animal
care followed NIH guidelines, under protocols approved by the Institute Animal Care and Use
Committee.
Gene discovery by macroarray screening
New cDNA clones of interest were isolated from a C.B17-Prkdcscid/scid (SCID) mouse
thymocyte cDNA library that was constructed and arrayed onto four large nylon filters as
previously described (Anderson et al., 1999; Tydell et al., 2007). SCID thymocytes were used
as starting material because their mutant phenotype prevents T-cell development from
continuing through β-selection. Thus, >90% of these populations naturally consist of T-cell
precursors in the DN1-DN3 stages. To select for cDNAs that might encode gene regulatory
factors, four “macroarray” filters containing approx 73,000 clones were screened as previously
described (Tydell et al., 2007) with probes designed to identify conserved domains associated
with transcription factors.
To make these initial probes, gene sequences of representatives from various transcription
factor families were aligned using ClustalX and primers were designed to their DNA binding
domains or protein interaction domains. Primers used are tabulated in Table 1. The putative
functional domain coding regions were then amplified from bulk SCID thymus cDNA and gel-
purified. Domain-specific DNA probes were generated by random priming in the presence of
α-32P dCTP, using the gel-purified PCR amplification products as templates. Probe was
hybridized to the macro-array filters overnight and washed with 3–4 low stringency washes to
enable fully and partially matched hybrids to be detected. Macroarray filters were exposed to
film and clones identified by positively hybridizing spot pairs that were picked from the
archival library for further analysis as previously described (Tydell et al., 2007). A total of
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1490 clones were selected into 96-well plates for sequencing and re-arraying onto smaller nylon
filters.
Sequencing was performed by the modified Sanger’s method at the Institute for Systems
Biology, Seattle, WA. The sequences were identified by BLASTn, BLASTx
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), and BLAT alignments against the Genbank “nr”
databases and the mouse genome (up to builds 35 & 36; http://genome.ucsc.edu). New
sequences that appeared to encode transcription factors or potential transcription-modifying
factors, as well as sequences that defined new splice isoforms of known transcription factor
genes, were submitted to Genbank as Expressed Sequence Tags (accession numbers listed in
Table 2).
Primary T-lineage cell samples
Cell populations of interest were collected by fluorescence-activated cell sorting (FACS), and
cells were processed in Qiazol (Qiagen, USA) for RNA. RNA was purified using Qiagen
RNAeasy kits (Qiagen), and treated with RNase-free DNaseI (Ambion) to remove genomic
DNA contamination before conversion into first strand cDNA using Superscript Reverse
Transcriptase (Invitrogen).
To isolate intermediates in T-cell development, antibody-mediated depletion with magnetic
beads and multiparameter fluorescence-activated cell sorting (FACS) were used as previously
described (Taghon et al., 2006; Yui and Rothenberg, 2004; Anderson et al., 1999). DN subsets
were sorted from wild type C57BL/6 mouse thymi that were first depleted for CD3, CD8,
TCRβ, TCRγδ, NK1.1, Gr-1, F4/80, B220, and Ter119. For “Series A”, cells were sorted into
DN1 (or ETP, early T-cell precursor)(CD117+ CD44+ CD25−), DN2 (CD117+ CD44+ CD25
+), DN3 (CD117− CD44− CD25+), and DN4 (CD117− CD44− CD25−). For “Series B”, cells
were sorted into DN1, DN2, DN3a, and DN3b subsets using CD27 to split the DN3 subsets as
described previously (Taghon et al., 2006), and isolating DN4 cells as CD44− CD25− CD24
+. To examine DN subsets from Rag2−/− mutant thymus, first 10% of dissociated thymocytes
were reserved to sort for DN2 = Thy1.2+ CD44+ CD25+ and DN3 = Thy1.2+ CD44− CD25
+ stages. The remaining 90% cells were depleted of CD24, Gr-1, F4/80, and Ter119 and then
sorted to separate Sca-1+Thy1− (precursor-enriched) and “pre-NK” = Sca1− Thy1+/− subsets
(David-Fung et al., 2006). These “pre-NK” cells are strongly enriched for expression of NK
cell genes such as perforin and Id2 (Wang et al., 2006; David-Fung et al., 2006; Wang et al.,
1998).
To analyze the development of fetal hematopoietic precursors developing in OP9-control or
OP9-DL1 culture, Lin- c-Kit+ CD27+ multilineage precursors (Lin = Ter-119, CD19, F4/80,
Gr-1) were isolated by FACS and cultures were established exactly as described previously
(Taghon et al., 2005). In these experiments, OP9-control cultures generated B cells
predominantly while OP9-DL1 cultures generated T cells. Samples were generated from two
independent large-scale time course experiments, one of which was a 10-day time-course also
used for previous analyses (Taghon et al., 2005; Tydell et al., 2007), and another set in which
cells retaining precursor phenotypes were re-sorted after the first two days, returned to OP9
coculture, and harvested after just 4 days overall. Some samples from these time-courses were
also sorted again at day 4 to re-isolate cells retaining the Lin− c-Kit+ CD27+ precursor
phenotype and to separate these from CD27− Mac-1+/Gr-1+ cells that had also been generated
in the cultures.
To assess gene expression in later T-cell development, thymic cells from wild type C57BL/6
mice were sorted by FACS directly to isolate double positive (DP) and single positive CD4+
cells, while another aliquot of the thymocytes was first depleted of CD4, B220 and NK1.1
expressing cells and then sorted to isolate double negative (DN) and single positive CD8+ cells.
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The markers used were: DN = CD24+ CD4− CD8−, DP = CD4+ CD8+, CD4 SP4 = CD4+
CD8−, CD8 SP = TCRβ + CD24− CD4− CD8+. TCRγδ cells were obtained from TCRβ−/−
thymocyte populations that were depleted for CD4 and CD8 prior to sorting for expression of
CD3ε and TCRγδ. To assess non-T lineage expression in adult tissues, pro-B and pre-myeloid
cells were prepared from Rag2−/− mutant bone marrow as described previously (Tydell et al.,
2007).
Quantitative real-time reverse transcriptase-dependent PCR
Quantitative reverse transcriptase-dependent PCR (qPCR) was performed to measure gene
expression in different samples of cDNA from the cells described above. Primers were designed
to genes of interest using the PrimerExpress™1.5 (ABI) or Primer3
(http://fokker.wi.mit.edu/primer3/input.htm) programs. They were designed as far as possible
to span introns of > 200 bp length, to avoid amplification of genomic DNA. Intron-exon
information was verified from Ensembl (http://www.ensembl.org) and UCSC mouse genome
assemblies. Primers utilized are shown in Table 3. Many primer sets used in this study have
also been reported previously (Anderson et al., 2002b;Anderson et al., 2002a;Hernández-
Hoyos et al., 2003;Yun and Bevan, 2003;Yui and Rothenberg, 2004;Anderson et al.,
2004;Dionne et al., 2005;Taghon et al., 2005;David-Fung et al., 2006;Taghon et al.,
2006;Franco et al., 2006;Taghon et al., 2007;Tydell et al., 2007). Standard curves were run for
new primers to select sets with dilution curves giving close to the theoretical value of ΔCT 3.3
per tenfold dilution. Note the anomalous titration behavior of two primer sets, Stat5b and
Thrap3 (Table 3), which should be treated with caution, but the great majority showed
amplification consistent with 1.8–2.0 fold amplification per cycle. Samples were run in
triplicate on an ABI Prism 7700 or 7900HT realtime PCR machine, and thresholds were set
uniformly across all genes analyzed with a particular reference standard to calculate ΔCT =
CT(gene) − CT(standard). Levels of expression were converted to units of β-actin or GAPDH
expression using the formula: expression = (1.9)−ΔCt.
Each gene was interrogated in at least two independently sorted sets of samples (two sets = 1
“series”) for verification of gene expression patterns, and key genes were analyzed in four or
more independently sorted series of samples. Sorted cell cDNA inputs were routinely
normalized by expression of GAPDH and β-actin; in early analyses, expression of Hprt was
also assessed (not shown). To test for genomic DNA contamination in cDNA samples, primers
IL2-UP, from the upstream non-transcribed region flanking the mouse IL2 gene were used
(Adachi and Rothenberg, 2005). In general, patterns of expression defined by changes in level
>3 fold were highly reproducible among independent experiments [also see (David-Fung et
al., 2006; Rothenberg et al., 2008)]. However, “absolute” levels of expression measured
relative to standards could vary over time according to detailed conditions of measurement,
with the worst differences (5–10 fold) associated with certain primer sets. Thus all analyses
shown are based on simultaneous measurements across a full series of samples, and patterns
with little variance cannot be accurately distinguished.
Clustering Algorithms
Correlation values between the expression profiles of all genes in a data set were calculated
for each Series, and they were post-processed by sorting on Hierarchical (tree)(Baldi and
Brunak, 2001) or Minimum Spanning Tree (MST) algorithms as described in Supplementary
Methods. The values from qPCR analyses used were log transformations of averages of the
two independent sets of data. Data from Series A and from Series B were analyzed separately.
A method of visual representation of the correlation data was developed as a matrix of the
Pearson correlation values between expression patterns of each gene with those of each other
gene. In this matrix, each value of entry ‘ij’ (row i, column j) reports the correlation between
David-Fung et al. Page 5
Dev Biol. Author manuscript; available in PMC 2010 January 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
expression of gene ‘i’ and gene ‘j’, while ‘ji’ would show the correlation between the same
two genes across a 45 angle of reflection. For 60 genes processed, e.g., there are 60 entries per
gene with a value of 1 for each self-correlation, with these self-correlations marking the
diagonal of the matrix. A grid of values relating to colors from blue to red were assigned: blue
representing a maximum correlation of +1, yellow a lack of correlation, and red a complete
anticorrelation at −1. This representation was applied to the genes in lists ordered either by
hierarchically clustered sorting (shown) or by minimum spanning tree sorting (not shown). In
the hierarchically sorted coldmap clusters, the red numbers above the dendrogram denoted the
chronological order of the links drawn, with low numbers for links between genes or groups
of genes with very similar expression patterns and high numbers between groups of genes with
more distinct expression patterns. Cluster or branch-cutting was based on these link-orders.
The minimum spanning tree (MST) algorithm comes from the cluster analyses of Xu and
Olman (Olman et al., 2003; Xu et al., 2002); where points are ordered so that the sum of their
linkages is minimized. This provides a way to view the data as a fully-connected graph with
the data points as the vertexes and the distances as the edges. A tree can be obtained from this
graph, such that each vertex is visited once and the sum of the edges is minimal. Details of the
algorithms used for MST and hierarchical clustering are presented in the Supplementary
Material.
To visualize the patterns represented by each cluster as well as their relationships, Self-
Organizing Matrix (SOM) analysis (Tamayo et al., 1999) was also applied to the data for each
Series separately. Log-transformed expression measurements for each gene across the DN
subsets were normalized to a row mean of 0 and then organized into 10–12 clusters by
GeneCluster2 software (http://www.broad.mit.edu/cancer/software/genecluster2/), using two-
row and three-row organizations. The configurations presented explain >84% of the gene
expression variance in each Series.
RESULTS
A global search for transcription factor genes expressed in early T-lineage cells
Most factors currently known to play a role in early T-cell development have been discovered
indirectly, either by serendipity or by cis-regulatory analysis of genes expressed by mature T
cells. To search more broadly for transcription factors or transcription factor variants that act
during early T-cell development, we took a gene discovery approach based on de novo cloning.
As a source enriched for cDNAs expressed during the choice of a T-lineage fate, we used a
macroarray of two cDNA libraries prepared from immature thymic cells whose development
beyond the point of commitment was blocked by a “severe combined immune
deficiency” (scid) mutation in the Prkdc gene (Anderson, 1999). These populations are ~102
fold enriched, relative to normal thymus, for immature T-lineage cells in stages between entry
into the thymus and commitment (Fig. 1a). This master arrayed library has been a valuable
source of stage-specific cDNA clones for previous studies (Anderson et al., 1999; Chen et al.,
2001; Tydell et al., 2007). To recover candidate transcription factor coding sequences, we
screened filters spotted with the arrayed library iteratively by hybridization with specific probes
for diverse transcription factor domains. Probes were made to detect canonical DNA binding
domain types or protein-protein interaction domain types (Table 1), as described in Materials
and Methods. Clones significantly reactive with these probes were recovered from the arrayed
archive and sequenced. Sequences predicted to encode regulatory factors, chromatin modifying
proteins, and potentially relevant signaling molecules were submitted to GenBank as
2Present address: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545
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summarized in Table 2. Diverse splice isoforms of known genes (e.g. Tfdp1, Rbak, and
Zfp426) and many genes predicted to encode transcriptional repressors (KRAB and SCAN
domain Krüppel-type zinc finger proteins) were identified from the SCID thymus cDNA
library.
Expression of the newly identified transcripts was monitored in purified immature thymocytes
from wildtype mice by qPCR, together with expression of known T-lineage differentiation
genes and previously identified T-lineage transcription factors, as described in the following
sections.
Stages of developmental activation of T-cell genes
Cells in the first stages of T-cell development that enter the thymus are diagrammed in Fig.
1A. These stages are defined as “double negative” (DN), as they lack mature T-cell markers
CD4 and CD8. In order of maturity, these stages are termed DN1 (or early T-cell precursor,
ETP), DN2, DN3a, DN3b, and DN4. Progression through these stages is profoundly dependent
on Notch/Delta signaling. Yet the maturation process is independent of the T-cell receptor
(TCR) until after the DN3a stage. At that point the cells arrest at a developmental checkpoint
and cannot proceed further until successful rearrangement of TCR gene segments occurs. This
conditional arrest point is known as the “β-selection checkpoint”. During the initial stages of
intrathymic development, T-cell precursors retain certain alternative developmental potentials.
Precursors may develop along natural-killer and/or dendritic cell lineage pathways. However,
by the DN3a stage, the cells are committed to some form of T-cell fate.
Because T-lineage differentiation occurs continuously in mammals throughout life beginning
at mid-gestation, the normal thymus is in a dynamic steady state in vivo. To obtain a virtual
timecourse of early T-cell development for gene expression analysis, we sorted different
subsets of immature mouse thymocytes from postnatal, weanling mice, defining developmental
stages based on expression of the growth factor receptor c-Kit and markers CD44, CD25
(Ceredig and Rolink, 2002), and where appropriate, heat-stable antigen (CD24) and CD27
(Taghon et al., 2006). Four independent series of samples were prepared from normal, young
adult mice. DN1, DN2, total DN3, and DN4 cells were collected in each of the first two sets
(“sets 1 & 2”, Series A), whereas in the second two sets (“sets 4 & 5”, Series B) the DN3 cells
were further subdivided into DN3a (pre-selection) and DN3b (the first stage past β-selection).
The timing of major positive regulatory changes that confer T-lineage identity was revealed
by expression of known T-cell differentiation genes, such as those encoding TCR/pre-TCR
complex components CD3ε and CD3γ, kinases Lck and ZAP70, the specific linker LAT, and
the surrogate TCR chain Ptcra, as shown in Fig. 1B. All these genes undergo substantial
increases in expression from DN1 to DN2 to DN3 or DN3a stage, with only ZAP70 expression
continuing to increase further beyond the DN3a stage. The most strictly T-lineage-specific of
these genes, CD3ε, CD3γ, and Ptcra, show a particularly steep upregulation between the DN1
and DN2 stages. In corresponding subsets of fetal thymocytes, the major increase in expression
of each T-lineage gene occurred similarly from the DN1 to the DN3 stage. One minor difference
was that the DN1 populations in those rapidly-developing cohorts appeared to show slightly
higher T-lineage gene expression than adult DN1 stage cells (David-Fung et al., 2006)(M.A.
Yui, data not shown). Because Notch signaling is critical for T-cell specification, the samples
were also assayed for expression of the Notch target gene Deltex1 (Dtx1). Deltex1 is clearly
upregulated in DN1 stage cells as compared to prethymic precursors (Tydell et al., 2007) and
is further upregulated during the DN2 to DN3 transition. Its pattern of upregulation, however,
fails to parallel the T-lineage-specific genes in their initial increase from DN1 to DN2 (Fig.
1B). Thus additional regulatory inputs besides Notch signaling are likely to be needed to set
the timing for upregulation of T-lineage genes.
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Definition of the regulatory gene set
The regulatory factor set that we assembled for expression analysis included the new candidate
genes and about 20 additional transcription factor genes already implicated in T-cell
specification by direct genetic or biochemical evidence (Rothenberg et al., 2008; Anderson,
2006; Murre, 2005; Rothenberg and Taghon, 2005; Staal et al., 2001). The total set of genes
assayed is listed in Table 3. Genes encoding factors with a close structural relationship to known
T-cell transcription factors were included in the set as well, because they might contribute
partially redundant or competitive activities.
Many of the newly identified candidates encoded zinc finger factors, often for which little
annotation is available. These included both Krüppel-type C2H2 zinc finger factors, likely to
bind DNA directly, and RING finger factors, likely to mediate ubiquitin E3 ligase functions
and/or other protein-protein interaction functions. Several Krüppel-type zinc finger factors
were predicted to be obligate repressors, based on the presence of KRAB and/or SCAN
domains in their sequences (Collins et al., 2001), e.g. Rbak, Zfp1, Zfp28, Zfp109, Zfp110,
Zfp287, Zfp316, Zfp382, Zfp426, Zkscan1, Zkscan5, Zscan21, and Zscan22. Four transcripts
encoded Zn finger factors with BTB domains, i.e. Lrf (Zbtb7a), Zbtb20, Zbtb48, and Zfp238.
Other genes were expected to encode transcriptional modifiers that work without direct DNA
binding (prothymosin α = Ptma), or contribute to chromatin remodeling (Jmjd3, Myst3, Mta2,
Mta3, NCoR1, NCoR2, SBF1) either to activate or to repress gene expression. Some genes
encoded members of known transcription factor families that had not individually been
implicated in T-cell development before, such as the POU-homeodomain factor Pou6f1 (Brn-5)
and the Ikaros relative Eos (Ikzf4). Transcripts encoding novel isoforms of Rbak, Zfp426, and
the winged-helix transcription factor TfDp1, were also identified and later specifically assayed,
although these did not reveal a different pattern from the expression of the canonical forms.
These novel regulatory candidates were monitored in parallel with the known essential factors
(Rothenberg & Taghon 2005) E2A (Tcfe2a) and its partially redundant relative HEB (Tcf12),
GATA-3 (Gata3), Gfi-1, TCF-1 (Tcf7), Ikaros (Ikzf1), Myb, Runx1, and PU.1 (Sfpi1), and their
relatives GATA-2, Gfi1b, LEF-1, Mybl2, Runx2, Runx3, and Spi-B. We monitored Ets1 and
Ets2, which may be implicated in TCR gene expression, and other Ets family members
associated with stem-cell, T-cell, or NK cell function. Also analyzed were other members of
the Ikaros family and members of the helix-loop-helix inhibitor (Id) family. As landmarks for
differentiation in the same samples, we assayed genes encoding the T-cell receptor signaling
component CD3ε; the Notch target gene Deltex1; and the growth factor receptors IL-7Rα
(CD127), IL-2Rβ (CD122), and GM-CSF-Rα (Csf2ra) to track changes in the responsiveness
of the cells to different environmental signals (Fig. 1B and data not shown).. In all, 80 different
candidate regulatory genes were assayed in sets 1 & 2 (series A), and 56 candidate regulatory
genes were assayed in sets 4 & 5 (series B). In a review (David-Fung et al., 2006) we previously
described a subset of the data from series B, for 19 genes, which is also included in this analysis
for context.
The great majority of the regulatory genes were detectably expressed in at least one
developmental stage at levels that were calculated to be above 10−2 times β-actin copy number.
For cells with the overall RNA content of immature thymocytes (~1 pg/cell), this is consistent
with a lower boundary of about 3 × 10−3 times β-actin level as the threshold for expression of
at least one copy per cell in the population. The comparability of series A and series B was
checked by assaying 13 transcription factor genes with important functions or well-marked,
distinctive expression patterns in both series: these genes encoded Ets1, Ets2, FOG-1
(Zfpm1), GATA-3 (Gata3), HEB (Tcf12), Id2, LEF-1, Pou6f1, PU.1 (Sfpi1), Runx1, Runx3,
SpiB, and TCF-1 (Tcf7). In general, there was excellent agreement between the overall patterns
of expression measured across the developmental stages. Also, for more than half of these
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genes there was also excellent agreement with the absolute measured expression levels (within
a factor of 2 or less).
Expression of landmark transcription factor genes and new candidates in normal early T-cell
development
Figures 2–4 present analyses of the expression patterns of the regulatory genes we monitored
in the immature DN T-lineage cells of series A and series B. In Fig. 2, actual qPCR results for
the genes are shown with genes in alphabetical order. Data from Series A samples are joined
by solid curves, data from Series B samples by broken-line curves. All the expression levels
measured in Fig. 2 are presented in units relative to β-actin in the same samples. Several
methods were used to group these regulatory genes based on their patterns of expression during
T-cell specification. Fig 3 shows the correlations between expression patterns of different genes
within series A and series B. Here, genes are listed in an order determined by hierarchical
clustering (shown left of y axis), and the plot uses a color scale (“cold map”) to show pairwise
correlations between expression patterns of each gene (y axis) with those of every other gene
(x axis). Gene expression patterns were also organized by the Minimum Spanning Tree method
of Xu et al. (Xu et al., 2002), which discerned similar groups (G. Buzi, data not shown). Finally,
Figs. 4A, B show representative self-organizing matrix (SOM) clusterings of the normalized
expression patterns for genes analyzed in each series (membership of clusters listed in
Supplementary Table 1). The boundaries between clusters are somewhat flexible, but Fig. 4C–
F show actual expression levels of genes that typify common patterns or features of regulatory
factor expression: “rising”, “declining”, “DN3 peak”, and “legacy and loss”.
Genes with minimally changing RNA expression: legacy genes—Each clustering
method showed that the majority of genes we monitored were expressed in a sustained,
minimally changing (<3 fold) pattern from DN1 to DN3 stage. This inter-correlated group is
the most dominant feature shown in Fig. 3 (especially 3A), and encompasses not only the genes
with “legacy” patterns shown in Fig. 4F but also many genes not shown in Fig. 4 and genes
with very low amplitude DN3 peaks in Fig. 4E. Although many of these stably expressed genes
are poorly characterized, it must be emphasized that this group also includes many of the factors
known to be essential for T-lineage specification from genetic evidence. It includes Myb,
MLL1, Ikaros (Ikzf1), Gfi-1, GABPα, Stat5b, Oct1 (Pou2f1), and TOX, all of which have
critical roles in T-cell development and/or in T-cell differentiation gene expression [rev. in
(Rothenberg et al., 2008;Rothenberg and Taghon, 2005)(Aliahmad and Kaye, 2008;Yao et al.,
2006;Ernst et al., 2004;Xue et al., 2004;Wilkinson et al., 2002;Chen and Kuo, 2001;Ullman et
al., 1990)]. The stably expressed group contains at least as many known contributors to T-cell
development as the group of genes that are sharply upregulated (next section). Furthermore,
in terms of the provision of regulatory inputs for other genes in the T-lineage program, genes
such as FOG-1 (Zfpm1), Gse1, Yy1, and Zfp598 contribute stably as well, which show slightly
different expression trends from most “legacy genes” (Supplementary Table 1) but with very
small changes in amplitude. The prevalence of regulatory or candidate regulatory genes
showing stable expression in early T-cell development contrasted remarkably with the massive
changes in T-lineage gene expression and developmental potential that occur across this
interval (cf. Fig. 1B).
Upregulated genes—A surprisingly small group of genes showed definite upregulation
(Fig. 4C) during DN1 to DN3 progression. Most of the regulatory genes in this group were
previously known to be involved in T-cell specification, i.e., Gata3, Ets1 and Ets2, Tcf12, Tcf7,
Lef1, Satb1, Ikzf3 (Aiolos), and Id3. Of the less-studied factors added to this group, Cutl1,
Hmga1, Jmjd3, Mlf2, Mybl2, Pou6f1, Ptma, and Zfp382 also appeared to increase in expression
with the onset of lineage-specific gene expression. However, most of these upregulated factors
increased relatively little across the DN1 to DN3 progression, with gross increases of <10-fold.
David-Fung et al. Page 9
Dev Biol. Author manuscript; available in PMC 2010 January 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Some of them peaked at DN3 and decreased again after β-selection (DN3b and DN4), a pattern
feature discussed further below, for an even weaker net increase.
Within the “rising” group, the timing of upregulation of different sets of regulatory genes
defined at least three different positive regulatory events. First, HEBalt (a promoter-use variant
of Tcf12 (Wang et al., 2006)) and Bcl11b underwent the most dramatic portion of their
upregulation at the DN1 to DN2 transition, as described elsewhere (Tydell et al., 2007). At the
next transition, from DN2 to DN3, Ets2, Lef1, and Pou6f1 were sharply upregulated, apparently
in parallel. Then, from DN3 to DN4 stage, Ikzf3 and Tbx21 were upregulated. Id3 appeared
unique in its induction in early DN3 stage (DN3a) to a peak in newly-selected DN3 cells
(DN3b), followed by a striking decline in the DN4 stage. The distinctive pattern seen for Id3
could reflect its preferential use in the TCRγδ lineage (Taghon et al., 2006). These results, in
accord with some previously reported data (David-Fung et al., 2006; Rothenberg et al., 2008;
Taghon et al., 2006; Tabrizifard et al., 2004; Morgan et al., 1997), emphasize that T-lineage
specification occurs in an ordered cascade.
Genes downregulated during specification—A prominent feature of the DN1 to DN3
progression was the downregulation of hematopoietic transcription factor genes Gfi1b,
Gata2, Bcl11a, and of genes encoding several members of the Ets, Helix-loop-helix, C/EBP,
and Runx transcription factor families. Many of these downregulated genes (Sfpi1 (PU.1),
Tal1 (SCL), Id2, Cebpa, Bcl11a) are functionally implicated in non-T cell hematopoietic
differentiation programs (Herblot et al., 2000; Ikawa et al., 2001; Anderson et al., 2002b; Liu
et al., 2003; Lefebvre et al., 2005; Laiosa et al., 2006). Another “declining” gene, Erg, was
previously identified (Anderson, 2006; Anderson et al., 1999) and has recently been determined
to be crucial for stem-cell maintenance (Loughran et al., 2008). Genes encoding many factors
not previously associated with early T-cell precursors also fell into this group, e.g. Aff3, Elk3,
Etv6, Klf2, Lima1, Rnf149, Tsc22d1, and Zfp316 (possibly also Thrap3). Downregulation of
these factors again occurred in distinct stages. Some transcripts diminished mostly between
the DN1 and DN2 stage, including Tsc22d1, Lima1, Gata2, Cebpa and Cebpb, while others
fell most abruptly only after the DN2 stage (e.g., Tal1, Sfpi1, Gfi1b, Runx2 and Runx3, and
Elk3). The most dramatic shutoffs of gene expression were seen for PU.1 (Sfpi1) and SCL
(Tal1), which fell at least two orders of magnitude by the DN3 stage.
Multigene downregulation after the DN3 stage—The DN3 stage is when T-lineage
commitment first appears to be complete, when proliferation stops, and when survival first
becomes dependent on TCR signaling (β-selection). We expected most discontinuities to occur
between DN2 and DN3, with the T-cell identity stabilizing thereafter. However, a more
commonly observed pattern element was a rapid decline in expression after the DN3 stage.
This was seen both for genes that had been stably expressed from the DN1 stage (Fig. 4F) and
for some genes that were newly upregulated at the DN2 to DN3 transition (Fig. 4E).
Downregulation ranged from a slight decrease for some genes to virtual extinction of others.
The Notch-induced gene Deltex1 and the PU.1 relative SpiB showed abrupt, transient peaks of
expression at the DN3/3a stage followed by a sharp decline (Fig. 4E). Other genes were
downregulated sharply after more gradually reaching the high point in DN3/DN3a cells. These
included Runx1, Zfp287, and the Ikaros family member Ikzf4 (Eos), as well as Hes1 and
HEBalt, which were also reported previously (Wang et al., 2006;Tan et al., 2005;Yui and
Rothenberg, 2004). Even among genes that were also downregulated between the DN1 and
DN3 stages, Zbtb20, Klf2, Runx2, and even Id2 all showed their steepest downregulation after
β-selection. The shutoff of expression after the DN3a stage was the most conspicuous feature
of the expression pattern for the Ets-family gene Erg. In the cases of SpiB, HEBalt, and Erg,
at least, this downregulation appears to be permanent (see below) (Rothenberg et al.,
2008;Anderson et al., 1999). These results suggest that although developmental commitment
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appears to occur at the DN3 stage before selection, many “legacy” regulatory genes are shut
off only afterwards, apparently triggered by β- or γδ-selection.
Genes specifically expressed in thymic natural killer cells
One regulatory gene, Tbx21 (T-bet), showed an apparently anomalous pattern of expression in
these analyses. Although it was recovered from our macroarrayed SCID thymus library in
multiple clones, qPCR showed this gene to be expressed at very low levels in the DN1-DN3
T-cell precursor stages, with most of its expression beginning only as the cells progressed to
DN4. Since there is no β-selection in SCID thymocytes, this appears inconsistent with the
apparent high prevalence of Tbx21 transcripts in the SCID thymus cDNA library. Fig. 5 shows
that this is because Tbx21 is actually expressed selectively in thymic natural killer (NK) cells,
a population that is highly enriched in SCID thymocytes (Telfer and Rothenberg,
2001;Anderson et al., 1999;Wang et al., 1998). As in normal DN thymocytes, the
immunodeficient cells showed increasing Hes1 expression in DN2 and DN3 cells, a sharp rise
in Ets2 expression in the DN3 stage. As expected (Anderson et al., 1999), PU.1 (Sfpi1) was
expressed highly in a Rag-deficient population that contains the earliest T-cell precursors
(Sca-1+ Thy-1low), decreasing in DN2 and DN3 cells and in differentiating NK cells. By
contrast, Tbx21 expression was highly enriched in the pre-NK population, a subset which is
also marked by its very high expression of IL2rb (Fig. 5). High expression of Tbx21 was also
confirmed in mature TCRγδ cells (see below), in agreement with others (Yin et al., 2002).
Discordant or compensatory expression within transcription factor families
Ets, Runx, Helix-loop-helix, and Ikaros family transcription factors are all implicated in stage-
specific T-cell development and gene regulation. Our results, however, showed that these
families are continuously well-represented at all stages in early T-cell development. It is the
balance among family members that undergoes stage-specific developmental change. Fig. 6
(extracted from the data in Fig. 2) shows detailed patterns of expression for transcription factors
of some of these families. Some of the strongest changes in expression occur, in opposite
directions, among different members of the same structural families. Most dramatic are the
expression patterns in the Ets factor family. While PU.1 (Sfpi1) plunges, SpiB spikes and then
falls; and while Elk3, Etv6 (TEL), and Erg decrease, Ets1 and Ets2 increase (Fig. 6A).
Concomitantly, as Runx2 and Runx3 decrease, Runx1 increases (Fig. 6B). Ikaros family
members Ikaros (Ikzf1) and Helios (Ikzf2) are expressed fairly stably, but Aiolos (Ikzf3) dips
and then rises while Eos (Ikzf4) peaks and falls (Fig. 6C). Note also that even though Lef1 and
Pou6f1 are among the genes most sharply induced at the DN2 to DN3 transition, their respective
relatives Tcf7 and Pou2f1 (Oct1) are also being expressed in a more sustained pattern, at
apparently higher levels (cf. Fig. 2). The bHLH transcription factor families including SCL
and the E proteins are also highly dynamic, as are their inhibitors (Wang et al., 2006)(cf. Fig.
2).
As many “new” KRAB and SCAN domain zinc finger coding genes were identified in our
screen, and are possible candidates for negative regulatory components of the commitment
mechanism, it was also of interest to determine how these predicted repressors might be
regulated. As shown in Fig. 6D), these genes also showed a mixture of expression patterns:
many were expressed stably and at relatively high levels, while others, including the SCAN
domain factor Gfi1b, were downregulated at the DN2-DN3 or later transitions. None of those
identified were substantially upregulated during specification, however.
Similar or identical target sequences are thought to be bound by multiple members of the Ets,
bHLH, Ikaros, Tcf/Lef, and Runx families. If nuclear concentrations of these transcription
factor proteins follow the patterns of their RNAs, then these data imply that Ets, Runx, bHLH,
David-Fung et al. Page 11
Dev Biol. Author manuscript; available in PMC 2010 January 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
and Ikaros binding sites in target genes may be continuously occupied throughout early T-cell
development, but by shifting combinations of factors within these families.
Lineage specificity and kinetics of induction in vitro
The evidence presented so far suggests that stage-specific positive and negative regulatory
changes during the DN1 to DN3 progression are superimposed on a rich background of gene
expression continuing from the earliest stage through commitment. In this context, we revisited
the question of which regulatory genes in our study might be T lineage-specific. Not only genes
upregulated during commitment but also some of the genes with seemingly stable expression
could be candidates. Most cells in the earliest stage of adult mouse T-cell development, the
DN1 stage, have already been acted upon by the thymic microenvironment and are already
distinct from multilineage prethymic precursors, e.g. with respect to expression of Dtx1, Gata3,
Hes1, and Tcf7 (Heinzel et al., 2007; Sambandam et al., 2005; Tan et al., 2005; Tydell et al.,
2007). Thus we investigated whether the stable expression of regulatory genes from DN1 to
DN3 stage was actually continuing from prethymic precursors or was an immediate response
to thymic signals. For this, we made use of an in vitro differentiation system in which a cohort
of prethymic precursors can be traced over time as they enter the T-cell pathway (Schmitt et
al., 2004b; Schmitt and Zuniga-Pflucker, 2006; Taghon et al., 2005). The T-cell program is
triggered in hematopoietic progenitor cells by co-cultivation with stromal cells that have been
forced to express a Delta-type Notch ligand. In the absence of the Notch ligand, or at reduced
Notch signaling intensity, these same stromal cells support differentiation into B (and some
NK) cells but not T cells (Schmitt et al., 2004a). Thus a comparison of the differentiation of
the same precursor cells on stromal cells with and without Delta reveals not only discontinuities
from prethymic input cells but also differences between the T and B-cell programs.
In two independent series of time course samples, we tracked genes representative of each
expression pattern. The gene expression measurements from one well-characterized OP9
culture time course (Taghon et al., 2005; Tydell et al., 2007) are shown in Fig. 7. Similar results
were obtained in a second timecourse of four days overall, and in samples re-sorted from the
two timecourses at two or four days of culture (data not shown). B-cell specification was
tracked by upregulation of the Pax5 gene. In these samples, the Notch target gene Dtx1 and
previously characterized T-cell specific regulatory genes Gata3, Tcf7, and Bcl11b as well as
the T lineage-specific differentiation gene Cd3e were upregulated only under T-cell conditions
as previously reported (Taghon et al., 2005; Tydell et al., 2007). Those data are included here
again as a standard for T-lineage specificity. None of the other genes in this study showed
comparably strong T-lineage specificity. A group of other genes did show a weaker but
detectable preference for T-cell conditions, with either accelerated or more extensive
upregulation. These genes included Ets2, Foxp4, Myb, Rbak, Pou6f1, Satb1, Tcf12, and Tle3
(Fig. 7). In addition, “legacy pattern” representatives Mta3 and Stat5b appeared to be sustained
better from stem-cell levels in the T-lineage conditions than in the B-lineage conditions.
Even so, the great majority of the genes analyzed were not induced preferentially during T-
lineage differentiation under T-cell conditions. Although genes such as HEBalt and Pou6f1
are markedly upregulated in vivo at particular DN stages, they also were substantially induced
in the B-cell conditions. Of particular interest were the four regulatory genes, Ets1, Ets2,
Lef1, and Pou6f1, which are specifically induced during commitment to the T-cell lineage at
the DN3 (DN3a) stage and maintained thereafter. If this event represents the definitive
activation of T-lineage specific regulators, then these genes should show clear T-lineage
specificity. Indeed, Ets2 showed an increasing expression specifically in T-lineage promoting
conditions. But as already noted, Pou6f1 was clearly upregulated in B-cell precursors as well,
and Ets1 and Lef1 showed no sustained T-lineage preference at all. SpiB, also specifically
upregulated during the DN3 stage, was expressed considerably better in the B lineage cells.
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These results are consistent with a separate assessment of the T-lineage specificity of >70 of
these genes, in which we compared expression in adult DN pro-T cells with expression in
freshly isolated bone marrow myeloid cells and pro-B cells (Table 4B, columns 1–3). This
survey also included Cd3e, as a marker for T lineage specificity, the B-lineage specification
gene Pax5, and Bcl6, which encodes a factor crucial for mature B-cells and is reported to
provide physiological restraint on the expression of GATA-3 in peripheral T cells (Kusam et
al., 2003). The results confirmed that the overwhelming majority of the transcription factor
genes assessed were not T lineage-specific in expression. Of the genes analyzed in this series,
only Gata3, Tcf7, Pou6f1, Ets2, and TOX (not monitored in the OP9 culture samples) showed
an early T-lineage preference, i.e. with T-cell levels >3x greater than their levels in myeloid
and pro-B cells. SATB1 also nearly met this criterion (Bcl11b was not assayed in these samples).
Tbx21 was expressed more strongly in thymocytes than in myeloid or pro-B cells, but on closer
examination, it was strongly expressed only in TCRγδ cells and in unsorted mutant thymocyte
populations with a strong NK component (sorted wildtype DN cell value <0.15 of pooled “pan-
DN” reference value). In this comparison as well as in Fig. 7,Table 4 confirms that the levels
of Ets1 and Lef1 were no higher in pro-T cells than in pro-B cells, in agreement with their
known roles in B cell development (Wang et al., 2005;Reya et al., 2000).
Taken together, these results show that the regulatory genes with strongly T-lineage specific
expression are a very select subset of pro-T cell transcriptional regulators, and that within our
sample they are represented only by Gata3, Tcf7, TOX, and Bcl11b. These are all factors that
undergo most of their upregulation before the DN3 stage, i.e. before T lineage commitment.
But the notable result is that most of the regulatory factors in our set that are specifically induced
during the transition to T lineage commitment appear to be factors with substantial expression
in the B-cell or myeloid lineages as well.
Roles in later T-cell development for factors used in pro-T cell specification
The downregulation during β-selection that was observed for many of the new transcription
factor genes raised the question of whether factors sharing particular expression profiles during
the pro-T cell stages might also be used in parallel patterns in later stages of T-cell development.
Therefore, we also surveyed gene expression in a collection of samples representing later,
TCR+ stages of T-cell development, from CD4+ CD8+ (double positive, DP) to mature
CD4+ or CD8+ TCRαβ+ cells, and TCRγδ+ cells (Table 4B). In Table 4A, each qualitative
expression pattern as defined in the DN cells (from Figs. 2–4) is coded; then within each pattern,
the genes are further classified according to the overall magnitudes of their expression changes
from lowest to highest level, to distinguish weak and questionable expression changes from
strong ones. As for the non-T cell samples in Table 4B, expression of each gene in TCR+
subsets is presented in units relative to its expression in a pool of DN cell samples, and color
coded to help discern similar and different overall patterns of cell type specificity. A number
of the gene expression patterns shown here have been corroborated in a separate analysis with
independent sets of samples (Rothenberg et al., 2008).
While this survey was too small to establish definitive expression levels, Table 4B shows that
genes representative of each DN pattern could go on after β-selection to be expressed in diverse
combinations in each of these cell types. Not only genes with sharp ascending or descending
patterns, but also genes with “legacy” or “flat” expression patterns (Table 4, patterns 5 & 8)
showed notably divergent patterns of expression in TCR+ stages represented by DP, CD4 SP,
CD8 SP, or TCRγδ cells. As expected, progenitor-cell genes such as Sfpi1 that were repressed
during commitment were never re-expressed, but also an additional group of genes (e.g. Erg,
SpiB, Hes1, FUS, TfDp1, and Hmga1) remained profoundly downregulated in all TCR+ cells,
even though they were shut off only at β-selection, considerably later than Sfpi1 (PU.1), Lima1,
Tal1, and Gata2. Thus, a limited hit-and-run role during the pro-T cell stages is suggested for
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at least two distinct sets of regulatory genes. Other genes were downregulated selectively in
CD4+ CD8+ DP cells, in all TCRαβ+ mature cells, or in CD4+ or CD8+ cells specifically (Table
4B). Another, unanticipated finding was a group of transcription factors that appear to
distinguish sharply between TCRγδ cells and any of the TCRαβ+ subsets. Period1, Stat5b, and
Zbtb48 appeared to be downregulated in TCRγδ cells as compared to TCRαβ+ cells; Dmtf1
and NCoR2 were specifically elevated in TCRγδ thymocytes, along with known TCRγδ-
enriched factors Runx3 and Tbx21 (Taghon et al., 2006;Yin et al., 2002). Thus, transcription
factors inherited from prethymic precursors may still help to generate T-cell functional
diversity after the pro-T cell stages.
DISCUSSION
T cell lineage choice appears to encompass two major regulatory events: an asynchronous
upregulation of increasing numbers of T-cell genes from the DN1 to the DN3 stage, and a sharp
discontinuity in developmental potential when the cells undergo lineage commitment during
transition to the DN3 stage. These two processes are followed by a TCR signal-dependent
cascade of selective and developmental changes through the β-selection transition. If T-cell
development followed the model of B-cell development, then the onset of T-lineage gene
expression should reflect the activity of T-lineage specific transcription factors, and
commitment to the T-cell lineage would reflect the advent of the definitive T-cell specific
regulatory state. In this study, however, we see that the T-lineage commitment process departs
from expectation in several respects. First, the essential regulatory genes that are turned on in
a truly T lineage-specific way remain rare and do not seem to be upregulated during
commitment. Second, many of the regulatory changes that do occur in early T-cells are to
repress a subset of prethymically inherited genes rather than to upregulate new T-cell specific
factors, as noted by others (Kawazu et al., 2007). Third, at the DN3 stage when commitment
is thought to occur, the regulatory genes turned on are mostly not T-lineage specific. This
suggests that the detectable evidence of commitment at this stage may be a readout of a more
general cell biological function rather than a cell type identity function as such. Finally, we
show that the loss of factors inherited from the prethymic, multipotent progenitor state may
only be completed during β-selection. The β-selection (or γδ-selection) process may therefore
contribute a larger aspect of the commitment mechanism than has previously been recognized.
A few caveats need to be stated. First, our analysis is not a complete accounting for all
transcription factor genes. Although the gene discovery methods we have used here and in
related studies (Anderson et al., 1999; Tydell et al., 2007) have expanded the pool of known
candidate regulatory molecules (and their splice isoforms) in early pro-T cells, our gene lists
should be considered as a complement to those in microarray studies as in work by the groups
of Petrie, Staal, Ogawa, and Melchers (Tabrizifard et al., 2004; Dik et al., 2005; Kawazu et al.,
2007; Hoffmann et al., 2003). In contrast to this study, most of the recent microarray studies
cited have not addressed how different patterns of expression might be related to lineage
specificity. Where our data overlap with these published reports, they are in general agreement,
but each kind of study includes genes that are not highlighted in the other. A second caveat is
that the RNA-centered analyses used here almost certainly miss some levels of regulation that
alter protein levels between stages at which RNA levels are constant. Known examples relevant
to T-cell development are the cases of E2A (Engel et al., 2001) and GATA-3 (Yamashita et
al., 2005; Kusam et al., 2003; Hernández-Hoyos et al., 2003), both of which could be more
sharply regulated between certain cellular states than their transcript levels reveal.
Nevertheless, even if we miss some changes in active factor levels when RNA expression
appears “flat”, when we do see major changes in RNA level, it is very likely that protein
activities are also changing.
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This regulatory gene expression analysis sheds light both on the cellular states that make up
the stages of T-cell development and on the status of the regulatory molecules that may promote
transitions between these stages. Considering these regulatory genes simply as indicators, the
gene expression patterns shown here increase greatly the number of “dimensions” of data we
have to distinguish DN1 from DN2 from DN3 pro-T cells. Instead of relying only on c-Kit,
CD44, and CD25 to track normal developmental progress, the distinctively timed
downregulation patterns of PU.1 (Sfpi1), SCL (Tal1), Gfi1b, Erg, Zfp316, Runx2 and Runx3,
and Elk3 can also be used together with the distinctively timed upregulation patterns of
Bcl11b, Ets2, Lef1, Id3, and Pou6f1 to provide a much finer-grained picture of normal or
abnormal developmental progression. The downregulation at β-selection that normally affects
Hes1, SpiB, Erg, HEBalt, and genes like Zbtb20 and Zfp287 can also be used to diagnose
abnormalities of passage through this checkpoint (Yui and Rothenberg, 2004). Consideration
of this expanded set of stage markers reveals reproducible variations of normal T cell
development, as between the normal adult pathway and the accelerated development in the
fetal thymus (David-Fung et al., 2006). In this case, because the “stage markers” actually
encode regulatory factors, the differences may eventually shed light on the mechanisms
controlling the differing rates of fetal and adult development.
The products of these regulatory genes also need to be considered as “drivers”. Changes in
gene expression from stage to stage ultimately arise from changes in transcription factor
activity. However, the often-subtle changes in expression of known essential regulators that
we report raise important questions about the amount and type of change that is needed to be
significant. Transcription factors work combinatorially in order to regulate target genes, and
even factors showing minimal change can be functionally important participants in the T-cell
developmental process through interaction with different partners. Thus, not everything that
is functionally important for activation of a particular target gene needs to change in level.
Among the factors known to be critical for T-cell specification (Rothenberg and Taghon,
2005; Anderson, 2006), some like Myb and Gfi1 may increase less than three-to five-fold
between the stem cell state and the committed DN3 stage (Tydell et al., 2007; Rothenberg et
al., 2008). These precedents suggest that “legacy” factors generally could also be potential
participants in T-lineage specification, changing their functions through interaction with
different partners (Sieweke and Graf, 1998).
Our results also suggest that what turns on different genes at different stages of the T-cell
development process is sometimes not so much the appearance of a new transcription factor
DNA-binding activity, but rather, the change in the identity of the dominant transcription factor
that can bind to a given DNA regulatory site. As we show here, the overall level of DNA
binding activity by Ets, Runx, and Ikaros family factors may be virtually constant from DN1
to DN3 stage. It is mainly the balance among different members of the family that undergoes
dramatic developmental change. Clearly some of these families can participate in causing these
changes through their own cross-regulatory relationships: Gfi1b repressing Gfi1, Runx3
repressing Runx1, and PU.1 repressing SpiB, Ets1, and Ets2 (Doan et al., 2004; Vassen et al.,
2005; Spender et al., 2005; Franco et al., 2006). But for the change among family members to
make a difference, it is likely that protein-protein interactions with other transcription factors
are affected by the swap of one family member for another, and not just simple affinity for a
DNA target site: there are clear precedents for this among Ikaros family factors (Thompson et
al., 2007). By extension, each of the members of these families may compete with the others
functionally. For example, as the cells progress from DN1 to DN3, downregulation of Runx2,
Runx3 and Gfi1b could greatly enhance the impacts of the slight upregulation of Runx1 and
Gfi1, on target genes for which these family members are not functionally equivalent.
There are two crucial watersheds in the T-cell specification process that need to be explained
in regulatory terms, and our results shed light on what they actually entail. These are, first, the
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onset of T-lineage gene expression from DN1 to DN2, while the cells are apparently still
multipotent, and second, the loss of multipotency as the cells reach the DN3 stage. This work
and previous data (Tabrizifard et al., 2004; Dik et al., 2005; Tydell et al., 2007) show that the
DN1 to DN2 transition involves only modest increases in expression of two T-lineage specific
regulators (GATA-3 and TCF-1) and the dramatic upregulation of a third, Bcl11b. But although
our gene discovery strategy has yielded many “new” potential transcriptional regulators in
early T-lineage cells, no new candidates are both T-cell specific and significantly upregulated
at this time. This conclusion is also supported by published microarray data (Dik et al., 2005;
Tabrizifard et al., 2004; Hoffmann et al., 2003). Could GATA-3 or TCF-1 be the main driver
of T-cell gene activation at the DN2 stage? This seems questionable because the major
upregulation of these factors occurs much earlier, in entry to the DN1 stage (Tydell et al.,
2007), which can be multiple rounds of proliferation before the DN2 stage (Petrie and Zuniga-
Pflucker, 2007). Notch inputs seem to be needed throughout, and there is little indication from
Hes1 or Dtx1 expression that there is any special intensification of Notch signaling at this point
[rev. in (Rothenberg et al., 2008)]. Bcl11b is of great interest, but seemingly is not required for
development even to the DN3 stage (Inoue et al., 2006). While Gfi1 and E protein genes are
somewhat upregulated, they are not T-lineage specific. Therefore, a major timing element in
this initial phase of specification may be an increased permissiveness for the activity of T-
lineage specific genes through the downregulation of multiple DN1 and prethymic regulatory
genes. It may indeed be the downregulation of antagonists that enables stably transcribed
factors like E2A to undergo sudden gains in potency, e.g. by post-transcriptional mechanisms,
during the DN1 to DN2 transition (Engel et al., 2001).
The results also imply that the commitment process itself has a compound nature that is masked
in conventional comparisons between DN2 and DN3 cell potential. Negative regulation of
Gfi1b, SCL, PU.1, and other factors should play a role. But the surprise is that the factors
specifically upregulated during commitment are almost all shared between the T lineage and
other cell types, with little if any preferential expression in T cells as opposed to B cells.
Ets2 upregulation and the transient hyperactivation of Notch pathway target genes are the two
main positive events that are T lineage-biased; but the Notch activation is not a stable change
and the Ets2 activity appears to remain low compared to its pan-lymphoid relative Ets1. Ets2
may have a later specific role in T cell development (Zaldumbide et al., 2002), as our OP9 time
course captures only the beginning of its upregulation (M.A. Y., data not shown), but its
expression is not actually T-lineage specific, as it is expressed in myeloid cells as well (Ross
et al., 1998). Thus the transition from multipotent to committed may not use an exclusively T-
lineage specific mechanism. Note that the DN3 stage in adult mouse thymocytes is associated
with a proliferative halt (Petrie and Zuniga-Pflucker, 2007), with growth resuming only if β-
or γδ-selection is successful. Conceivably the change assayed as “commitment” is primarily a
loss of proliferation, before new functions are conferred during the β-selection process. A
permanent lockdown of commitment might only be required to preserve lineage fidelity if and
when proliferation might resume. Thus it is also notable that our results show another major
phase of repression during β-selection, when a large subset of the “legacy” genes, which had
been stably expressed through the DN3 stage are finally turned off. In this altered regulatory
environment, the proliferation associated with β- and γδ-selection would not only dilute out
pre-existing transcription factor proteins but also provide opportunities to remodel chromatin,
which would not be available in G1 arrest in the DN3 stage. Thus it may be only through β- or
γδ-selection that commitment can actually be converted into a stable and heritable condition.
In perspective, the induction of Tcf7 and Gata3 and then Bcl11b, all in the earliest steps of T-
cell development, remain the most T-lineage specific of all the regulatory features studied here.
Their initial upregulation occurs in the stages when cells are still multipotent, and our results
show that few if any other T-lineage specific regulators are likely to be added as the cells
undergo lineage commitment. What occurs instead appears to be the stripping away of other
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alternative pathway regulators and neutralization of inhibitory influences, so that a latent
identity already instilled in the earliest intrathymic precursors can be stabilized and revealed.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Landmarks for early T-cell lineage development. (A) Diagram of stages of early T-cell
development. (B) Expression of T-cell differentiation genes at successive stages of T-cell
development. Samples are from “Series B”, except that Il2rb and Il7ra are shown for samples
from Series A. For primer sequences, see Table 3 and (Taghon et al., 2007;Franco et al.,
2006). Gene expression levels are expressed in units relative to β-actin measured in the same
samples.
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Figure 2.
Regulatory gene expression patterns through early T cell development. Gene expression levels
are shown for the putative regulatory genes in this study, arranged alphabetically in order of
gene names. Gene expression levels are measured by qPCR using primers shown in Table 3,
and the geometric means of values determined from the two independent sets within each series
are plotted on a log10 scale relative to the expression of β-actin in the same samples (0 =
log101 = level of β-actin). Data from both “Series A” and “Series B” are combined in these
graphs, with Series A measurements joined by continuous line spline curves and Series B
measurements joined by broken-line spline curves. One group of Series B measurements that
were determined separately from all the others is indicated by dotted curves (Mitf, Sox4,
Bcl11a, Cebpa, and one set of Zfpm1). Where the same genes were analyzed in both series,
both sets of values are shown. In some cases (SpiB-1, SpiB-2; LRF, LRF*), the same genes
are assayed with different primer sets. LRF* = primers from Maeda et al. (Maeda et al.,
2007). GATA-3-r = GATA-3 reassayed on the same Series B samples with the same primers,
but by a different investigator > 1 yr after initial Series B measurement (David-Fung et al.,
2006); included to show reproducibility. To align the Series A samples (DN1, 2, 3, and 4) with
the Series B samples (DN1, 2, 3a, 3b, and 4), values were plotted on an x/y plot in which DN1
was considered “1”; DN2 was considered “2”; DN3a was considered “3.0”; DN3b was
considered “3.7”; DN3 (unseparated), which is mostly DN3a, was considered “3.2”; and DN4
was considered to be “4.5”. Thus, the β-selection checkpoint is represented by “3.5”. The same
convention is followed in Figs. 4C–F and 6 as well.
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Figure 3.
Hierarchical clustering of putative regulatory genes based on pairwise correlations. (A) Genes
tracked in Series A. (B) Genes tracked in Series B. “Cold maps” are shown to depict the
correlation among gene expression patterns within each series, with blue representing full
correlation and red representing full anticorrelation as described in Materials and Methods. All
genes analyzed in each series are listed in the same order along both the y axis and the x axis
of each plot, with the origin at the upper left, so that the diagonal represents the perfect
correlations of each gene’s expression pattern with itself. The order of the genes on each axis
is set by hierarchical clustering of expression patterns as shown at the left of each matrix, with
red numbers indicating the closeness of relationship (low numbers: close; high numbers:
remote; see Supplementary Methods). Note that in this hierarchical clustering order, the
clusters drawn should be considered to have rotational symmetry. Blocks of color help to
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visualize genes that are regulated in parallel (blue blocks) or in significantly opposing ways
(orange/red blocks) through early T-cell development. Three major groups of genes with
decreasing, sustained (“legacy”), and increasing expression are identified with lines over
particular blocks in Panel A. Series B was used in a targeted way to assay many genes known
from sources other than this gene discovery study, and so panel B is more biased toward genes
with diverse, highly inflected expression patterns.
David-Fung et al. Page 25
Dev Biol. Author manuscript; available in PMC 2010 January 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4.
Clusters of genes defined by expression patterns and pattern elements. (A, B) Self-organizing
matrices of expression patterns of genes assayed in Series A (A) and Series B (B). Numbers
of clusters and 2-row orientations were chosen to account for at least 84% of the overall
variance of gene expression in each Series. Cluster number (c) and number of genes in the
cluster are indicated at the top of each panel. Names of members of each of the clusters are
listed in Supplementary Table 1; examples are shown in (C–F). (C) Genes in this study showing
an increase from DN1 to DN3 of >3 fold. Data extracted from Fig. 2. (D) Genes in this study
showing a decrease from DN1 to DN3 of >3 fold. (E) Genes with patterns featuring a major
peak in expression at DN3 (DN3a) followed by a substantial decline. (F) Examples of genes
showing steady “legacy” expression from DN1 to DN3, including all those with substantial
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decreases at β-selection. Note that distinctions between the groups in (C)–(F) are not clearcut.
Certain genes, e.g. SpiB and Id2, have a “legacy” element of expression but may appear more
appropriate for different categories when different primers are used (SpiB-1 vs. SpiB-2, DN3
peak) or in different sample series (Id2, declining). In some of these ambiguous cases the same
gene data are shown in two panels to illustrate different pattern features, e.g. Id2, Zfp110 and
Zfp287). Additional evidence for these pattern groupings comes from other independent
measurements (Rothenberg et al., 2008; Taghon et al., 2006; Yui and Rothenberg, 2004).
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Figure 5.
Gene expression in thymocyte subpopulations with a genetic block to β-selection: early T vs.
NK lineage gene expression. Realtime qPCR measurements are shown for subpopulations of
thymocytes from B6. Rag2−/− mice, sorted as described previously (David-Fung et al., 2006;
Anderson et al., 2002b; Wang et al., 1998). True DN1 cells are very rare in these thymus
populations, but the Sca-1+ Thy-1low subset contains T-lineage precursor activity while pre-
NK cells (Sca-1− Thy-1+/− CD24−) are marked by strong perforin expression (David-Fung et
al., 2006). Note distinctively high Tbx21 and Il2rb expression in the pre-NK cells.
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Figure 6.
Differential regulation of different members of the same transcription factor families. Gene
expression data, extracted from Fig. 2, are shown for: (A) Ets, (B) Runx, and (C) Ikaros family
members, and (D) for genes predicted to encode KRAB and SCAN domain-containing zinc
finger factors.
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Figure 7.
Cell type specificity of gene expression induced in hematopoietic progenitors on OP9 stroma.
Gene expression levels are shown in units relative to β-actin at successive two-day time points,
starting from multipotent c-Kit+ CD27+ Lin− hematopoietic precursors from fetal liver. Cells
were cultured for up to ten days on OP9-control stroma, which does not permit T-cell
development (blue shaded bars), and on OP9-DL1 stroma, which promotes T-cell development
(brown to yellow shaded bars). Black bars show gene expression in input cells. Cultures were
harvested for RNA preparation every two days. At day 4, cells from the cultures were collected
and those retaining a precursor phenotype (c-Kit+ CD27+ Lin−) were repurified before being
placed in fresh cultures for the remaining 2–6 days (Taghon et al., 2005). Similar results were
obtained in experiments where the cells were not repurified at an intermediate timepoint or
were repurified at day 2 instead (data not shown). By 6 d, ~50% of cells in OP9-DL1 culture
are at least DN2 stage, and ~30% of cells in OP9-control culture are CD19+ (Taghon et al.,
2005). Genes transiently induced on either stroma (e.g. Il2rb, Cebpa) reflect abortive
emergence of NK and myeloid cells (data not shown), which are then suppressed during
sustained culture under OP9-control or OP9-DL1 conditions.
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TABLE 1
Conserved Domain Primers for Macroarray Screen
A. AT-Hook L. Homoeodomain
AT-Hook.For 5′-ctccgaaagagcccagtgaa-3′ HOXB4.For 5′-cggagctcggccaagtctatga-3′
AT-Hook.Rev 5′-ggtttcctccctggagctgt-3′ HOXB4.Rev 5′-ccggttatggaacgagatcttga-3′
B. ARID M. Leucine Zipper
ARID.For 5′-ggacctttgaggagcagttcaa-3′ TSC.For 5′-gtgggaccgagccgctgcagat-3′
ARID.Rev 5′-ctcataggggtaaagatacttcat-3′ TSC.Rev 5′-gtcttcagcagattgttctcct-3′
C. bHLH N. LIM Domain
MyoD.For 5′-ccaccaacgctgatcgccgcaa-3′ Lim-1.For 5′-cggagattaccagagtgagta-3′
MyoD.Rev 5′-cgcagcagagcctgcagacctt-3′ Lim-1.Rev 5′-gcaagctgggctcaggacta-3′
D. Bromodomain 4.5Lim.For 5′-gtcaggaatgccacaagcccat-3′
Bromo.For 5′-catcattaaacaccccatggacctcagta-3′ 4.5Lim.Rev 5′-gcacaggatattcttgtccca-3′
Bromo.Rev 5′-gctcacctggcatcttggcaaatctcat-3′ O. NFAT
E. Chromodomain NFAT.p-For 5′-ctcctctgccagcttcatt-3′
Chromo.Chd1-For 5′-caaccatttatgctgtcgaa-3′ NFAT.p-Rev 5′-ggcagaggagcaaccaaa-3′
Chromo.Chd1-Rev 5′-ctgctgcttcagggtctctt-3′ NFAT.x.For 5′-cctttgagtgcccaagtatccaa-3′
Chromo.Cbx/Mpc2-For 5′-cttcgcggtggagagcat-3′ NFAT.x.Rev 5′-gagatgctgctggcaggacta-3′
Chromo.Cbx/Mpc2-Rev 5′-cctttccctgttctggaa-3′ P. PAS
F. Cut-Homoeodomain AHR.PAS-A.For 5′-caggcgctgaatggctttgt-3′
Cux.For 5′-gtcaaggaggtgctcaccgacaa-3′ AHR.PAS-A.Rev 5′-cttctgtatggatgagctcat-3′
Cux.Rev 5′-cagccacagctgcatacgcacaa-3′ AHR.PAS-B.For 5′-cgaaccaaaaacttcatcttca-3′
G. Ezrin-Radixin-Moesin (Protein Interaction) AHR.PAS-B.Rev 5′-gtctgcagcatggatgaact-3′
ERM.For 5′-gacctgaagaccacatacgatgaa-3′ PER.PAS-A.For 5′-ggaacccggataccttcgctgt-3′
ERM.Rev 5′-ctgcagggtctgcctggccagtt-3′ PER.PAS-A.Rev 5′-acgtcatgaggagccaggagct-3′
H. Forkhead Box PER.PAS-B.For 5′-gatccctcctgagaagaggat-3′
Fox.For 5′-tcacctatgccacccttat-3′ PER.PAS-B.Rev 5′-cagatcctgaggtaggtaa-3′
Fox.Rev 5′ctcctcttcttgcgaaactca-3′ Q. PDZ
I. GCM Box PDZ.For 5′-cctctgacaatctctagtctgaa-3′
GCM.For 5′-gcgcaacaccaacaaccacaa-3′ PDZ.Rev 5′-ctttgtagagtcatattcaa-3′
GCM.Rev 5′-cttctgccttctgtctctgactt-3′ PDZk1.For 5′-gcagaggcagctggcttgaa-3′
J. HLH PDZk1.Rev 5′-ccagcaccaacagagtagt-3′
Myf5.For 5′-caggctggccactgcctcat-3′ LAP.For 5′-gttgcgtttgctcagacgaga-3′
Myf5.Rev 5′-gttggtggtggtgcacctctt-3′ LAP.Rev 5′-caagcttgatgcaccgcgacgct-3′
K. HMG Box WEGbox.For 5′acagataatgggggttgggct-3′
SOX.For 5′-gcaagccccatgctaagct-3′ WEG/PHD.Rev 5′-gtattgaacattgtctgcgccatt-3′
SOX.Rev 5′-ggtgattggcatggcggct-3 W. ZINC FINGERS
R. PHD Btb/Poz
PHD.For 5′-gtgcttgcatgacatgtaataaa-3′ BTB/POZ.For 5′-catttgctgcagtgcctgaacgagca-3′
WEG/PHD.Rev 5′-gtattgaacattgtctgcgccatt-3′ BTB/POZ.Rev 5′-catctggagatagttggcagctgcaa-3′
ZIP/PHDf.For 5′-cagcagcattgaacagaagga-3′ ROG.For 5′-ggcaggagcaactaggatgat-3′
ZIP/PHDf.Rev 5′-ggtagtcccctttcatgttat-3′ ROG.Rev 5′-ggtcagtgggatcctctgat-3′
S. REL C2H2
NFkB.For 5′-gctattcggtgagtaaagaa-3′ Multizf.For 5′-gcctcacagatcaccgaga-3′
NFkB.Rev 5′-gtttttgtagccctattttcat-3′ Multizf.Rev 5′-ggaagaggcttaaattgtt-3′
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T. RNA Binding Domains Fog
hnRNP.A2/B1-For 5′-ggctgcaaggcctcattccatt-3′ FOG.For 5′-gccccaggatgaagagaaa-3′
hnRNP.A2/B1-Rev 5′-gcctatcggtaattatttcaatagt-3′ FOG.Rev 5′-gcagtctttgcaggggaa-3′
hnRNP.U-For 5′-caggggcgaggcagggccaa-3′ Gli
hnRNP.U-Rev 5′-gacacaccgtaggaagctctt-3′ GLI.spfc-For 5′-gagacaaactgccactgggat-3′
hnRNP.x-For 5′-ggagagtggtgcacgtatcaa-3′ GLI.spfc-Rev 5′-gctcacagatgtaaggcttct-3′
hnRNP.x-Rev 5′-gcaaccaccttttccaataaga-3′ Groucho
Rbm.For 5′-gaaccagaggtgcttcaagaa-3′ Grg.For 5′-gaaatgcacaaacagactgaaat-3′
Rbm.Rev 5′-cccttggtaatggatactcat-3′ Grg.Rev 5′-ggtgcttcttgtcatcttttatt-3′
U. STAT Ring Finger
STAT.For 5′-gaccctgtccctccctgtggt-3′ Ring/B-box.For 5′-gatcgaggatcttctgta-3′
STAT.Rev 5′-cccatgatagccccatcattcca-3′ Ring/B-box.Rev 5′-ggcctcatgattgctgta-3′
V. T-BOX ZIC
T-box.For 5′-gagatgatcatcactaagcaa-3′ ZICspfc.GLI-For 5′-ctgttccgcaaccgtggctt-3′
T-box.Rev 5′-ggcagcctctggctctccat-3′ ZICspfc.GLI-Rev 5′-gggcagcatagtgctcggat-3′
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TABLE 2
EST Sequences from SCID Thymocyte Library
Gene Alt Name EST ID# GenBank Accession # Date Submitted
ARHGEF2 39175456 EB739685 5/10/2006
39175457 EB739686
ARID1A 39175458 EB739687 5/10/2006
39175459 EB739688
BAHD1 39175460 EB739689 5/10/2006
39175461 EB739690
BRD3 38305921 EB359574 4/6/2006
38305922 EB359575
38305923 EB359576
BTF3 39175462 EB739691 5/10/2006
39175463 EB739692
Cbx4 39175464 EB739693 5/10/2006
CEBPd 39175465 EB739694 5/10/2006
39175466 EB739695
CENTb1 39175467 EB739696 5/10/2006
CIZ Zfp384 39175468 EB739697 5/10/2006
39175469 EB739698
39175470 EB739699
39175471 EB739700
39175472 EB739701
39175473 EB739702
CRABP1 39781094 EC277794 6/8/2006
39781095 EC277795
CSF2Ra 39781134 EC277834 6/8/2006
39781096 EC277796
CTBP2 39781097 EC277797 6/8/2006
39781098 EC277798
CUTL1 39781099 EC277799 6/8/2006
39781100 EC277800
DAPLE CCdc88c 39781101 EC277801 6/8/2006
39781102 EC277802
39781103 EC277803
39781104 EC277804
DBP 39781105 EC277805 6/8/2006
39781106 EC277806
DIMP Dmtf1 39781107 EC277807 6/8/2006
39781108 EC277808
DSC43 39781109 EC277809 6/8/2006
39781110 EC277810
39781111 EC277811
39781112 EC277812
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Gene Alt Name EST ID# GenBank Accession # Date Submitted
39781113 EC277813
39781114 EC277814
39781115 EC277815
39781116 EC277816
39781117 EC277817
ELK3 39781118 EC277818 6/8/2006
39781119 EC277819
39781120 EC277820
39781121 EC277821
39781122 EC277822
ELK4 39781123 EC277823 6/8/2006
39781124 EC277824
39781125 EC277825
ESR1 39781126 EC277826 6/8/2006
39781127 EC277827
39781128 EC277828
39781129 EC277829
39781130 EC277830
39781131 EC277831
39781132 EC277832
39781133 EC277833
FLI1 39877808 EC365110 6/13/2006
39877809 EC365111
39877810 EC365112
39877811 EC365113
39877812 EC365114
GATA3 39877813 EC365115 6/13/2006
39877814 EC365116
GIMAP6 39877815 EC365117 6/13/2006
GNAI2 39877816 EC365118 6/13/2006
39877817 EC365119
GSE1 39877818 EC365120 6/13/2006
39877819 EC365121
HKR2 Zscan22 39877820 EC365122 6/13/2006
HKR3 39877821 EC365123 6/13/2006
HMGA1 38305924 EB359577 4/6/2006
38305925 EB359578
38305926 EB359579
38305927 EB359580
38305928 EB359581
38305929 EB359582
38305930 EB359583
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Gene Alt Name EST ID# GenBank Accession # Date Submitted
38305931 EB359584
38305932 EB359585
38305933 EB359586
IARS2 39877822 EC365124 6/13/2006
IKAROS 39877823 EC365125 6/13/2006
39877824 EC365126
39877825 EC365127
39877826 EC365128
39877827 EC365129
39877828 EC365130
39877829 EC365131
39877830 EC365132
JMJD3 39877864 EC365166 6/13/2006
39877831 EC365133
39877832 EC365134
39877833 EC365135
KLF2 39877834 EC365136 6/13/2006
39877835 EC365137
39877836 EC365138
39877837 EC365139
39877838 EC365140
39877839 EC365141
39877840 EC365142
39877841 EC365143
39877842 EC365144
39877843 EC365145
KLF13 39877844 EC365146 6/13/2006
39877845 EC365147
39877846 EC365148
39877847 EC365149
39877848 EC365150
39877849 EC365151
39877850 EC365152
39877851 EC365153
39877852 EC365154
39877853 EC365155
KLF15 39877854 EC365156 6/13/2006
39877855 EC365157
39877856 EC365158
39877857 EC365159
39877858 EC365160
39877859 EC365161
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Gene Alt Name EST ID# GenBank Accession # Date Submitted
39877860 EC365162
39877861 EC365163
39877862 EC365164
39877863 EC365155
MTA2 40881949 EE265166 8/3/2006
MTA3 40881950 EE265167 8/3/2006
40881951 EE265168
NCOR2 40881952 EE265169 8/3/2006
PAX1 40881953 EE265170 8/3/2006
40881954 EE265171
PCBP2 40881955 EE265172 8/3/2006
40881956 EE265173
Per1 40881976 EE265193 8/3/2006
40881957 EE265174
POU2F1 40881958 EE265175 8/3/2006
40881959 EE265176
40881960 EE265177
40881961 EE265178
POU6F1 40881962 EE265179 8/3/2006
40881963 EE265180
40881964 EE265181
PPARd 40881965 EE265182 8/3/2006
40881966 EE265183
PPRC1 40881967 EE265184 8/3/2006
PurB 40881968 EE265185 8/3/2006
RARa 40881969 EE265186 8/3/2006
40881970 EE265187
40881971 EE265188
RBAK 40881972 EE265189 8/3/2006
40881973 EE265190
40881974 EE265191
40881975 EE265192
SBF1 41528217 EE663535 8/24/2006
SFPI1 41528238 EE663556 8/24/2006
41528249 EE663567
SOX4 41528260 EE663578 8/24/2006
41528271 EE663589
41528176 EE663494
41528187 EE663505
41528189 EE663507
41528190 EE663508
41528191 EE663509
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Gene Alt Name EST ID# GenBank Accession # Date Submitted
41528192 EE663510
SPI-B 41528193 EE663511 8/24/2006
SUPT5h 41528194 EE663512 8/24/2006
41528195 EE663513
TBX21 41528196 EE663514 8/24/2006
41528197 EE663515
41528198 EE663516
TCF3 E2A 41528199 EE663517 8/24/2006
41528200 EE663518
41528201 EE663519
41528202 EE663520
41528203 EE663521
41528204 EE663522
TCF7 38305934 EB359587 4/6/2006
38305935 EB359588
38305936 EB359589
38305937 EB359590
38305938 EB359591
38305939 EB359592
38305940 EB359593
38305941 EB359594
38305942 EB359595
38305943 EB359596
TCF12 HEB 41528205 EE663523 8/24/2006
41528206 EE663524
41528207 EE663525
41528208 EE663526
41528209 EE663527
THRAP3 41528210 EE663528 8/24/2006
41528211 EE663529
TLE3 41528212 EE663530 8/24/2006
41528213 EE663531
41528214 EE663532
Tmsb4x 41528215 EE663533 8/24/2006
41528216 EE663534
TRIM24 41528218 EE663536 8/24/2006
TRIM25 EFP 41528219 EE663537 8/24/2006
41528220 EE663538
TRIM28 41528221 EE663539 8/24/2006
TSC-22d1 41528222 EE663540 8/24/2006
41528223 EE663541
41528224 EE663542
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Gene Alt Name EST ID# GenBank Accession # Date Submitted
YY1 38305944 EB359597 4/6/2006
38305945 EB359598
38305946 EB359599
ZBTB20 39175474 EB739703 5/10/2006
39175475 EB739704
ZBTB7a 41528225 EE663543 8/25/2006
41528226 EE663544
41528227 EE663545
41528228 EE663546
41528229 EE663547
41528230 EE663548
41528231 EE663549
41528232 EE663550
41528233 EE663551
41528234 EE663552
41528235 EE663553
ZC3H5 41528236 EE663554 8/25/2006
41528237 EE663555
ZFP3 41528239 EE663557 8/25/2006
41528240 EE663558
ZFP28 41528241 EE663559 8/25/2006
ZFP32 ZFP637 41528242 EE663560 8/25/2006
41528243 EE663561
ZFP36 l2 41528244 EE663562 8/25/2006
41528245 EE663563
41528246 EE663564
41528247 EE663565
41528248 EE663566
ZFP41 41528250 EE663568 8/25/2006
41528251 EE663569
ZFP90 41528252 EE663570 8/25/2006
41528253 EE663571
ZFP95 Zkscan5 41528254 EE663572 8/25/2006
41528255 EE663573
ZFP110 41528256 EE663574 8/25/2006
41528257 EE663575
ZFP238 41528258 EE663576 8/25/2006
41528259 EE663577
ZFP286 41528261 EE663579 8/25/2006
41528262 EE663580
ZFP287 41528263 EE663581 8/25/2006
41528264 EE663582
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Gene Alt Name EST ID# GenBank Accession # Date Submitted
ZFP316 41528265 EE663583 8/25/2006
41528266 EE663584
ZFP358 41528267 EE663585 8/25/2006
41528268 EE663586
ZFP422 41528269 EE663587 8/25/2006
41528270 EE663588
ZFP598 41528272 EE663590 8/25/2006
41528273 EE663591
ZFP672 41528274 EE663592 8/25/2006
41528275 EE663593
ZFP691 41528276 EE663594 8/25/2006
41528277 EE663595
ZFPN1A4 Eos 41528278 EE663596 8/25/2006
41528279 EE663597
41528280 EE663598
41528281 EE663599
Zip67 41528177 EE663495 8/25/2006
41528178 EE663496
41528179 EE663497
41528180 EE663498
41528181 EE663499
41528182 EE663500
41528183 EE663501
Zipro1 41528184 EE663502 8/25/2006
41528185 EE663503
ZKSCAN1 41528186 EE663504 8/25/2006
41528188 EE663505
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TABLE 3
Primer sequences used for Quantitative PCR
New1 primers Gene tested Alternative name Primer Sequences (Forward; Reverse) Comments Titration quality2
+ 4632433K11Rik AK014606 5 -ACAAGACTGACAGAGAAGACTTACAGAAA-3 
5 -GGGCTAAAAGGACTTGGGAGTT-3 
Actb β-actin 5 -ACACCCGCCACCAGTTC-3 
5 -TACAGCCCGGGGAGCAT-3 
Aff3 LAF4 5 -TGACACCTCCCACCATGGA-3 
5 -TTTCCTCCGTAACGCATTCC-3 
*(−)
+ ARID1a Smarcf1 5 -ACGTGGGCGTTAGACACCAT-3 
5 -AATATTCCACAAGGAGCTCTAGCAA-3 
*(−)
+ Atxn2l 5 -CTCTCCCTGACCCCTACAGA-3 
5 -CAGGGACTTTCCCAGCTAT-3 
+ B2m β2-microglobulin 5 -TCACTGACCGGCTTGTATGCT-3 
5 -TGAGGCGGGTGGAACTGT-3 
Used in preliminary analysis
only
+ Bahd1 mKIAA0945 5 -TCCCGCTTGGAGGGATTC-3 
5 -AGTCCCCTGCTCCATATTGCT-3 
Bcl11a CTIP1 5 -GTCTGCACACGGAGCTCTAA-3 
5 -CACTGGTGAATGGCTGTTTG-3 
Tydell et al., 2007
Bcl11b CTIP2 5 –GGGCGATGCCAGAATAGAT–3 
5 –GGTAGCCTCCACATGGTCAG–3 
Primers from Tydell et al., 2007
+ Bcl6 5 -GTGGAGATGAAGCCTGTAGCA-3 
5 -CACTTGAATCGTGCAGTGGTA-3 
**(−); Not expressed in
thymocytes
+ Brd3 5 -AAATGCAGGTTCCCAACAAGTG-3 
5 -CGGCAATGACGGGTGTCT-3 
*(−)
+ Brd4 5 -CCCTGAAGCCATCTACACTACGA-3 
5 -ACCAGCAATCACGTCAACTTT-3 
+ Cbx4 5 -AGCTGATGGGATATCGCAAGAG-3 
5 -GTCTTGAAGCCCAGTCAGAACAT-3 
+ Ccdc88c Daple 5 -CCTGGGTGAAAACTTTTGGA-3 
5 -CTGGGGTCTATTTGCAGCAT-3 
Cd3e 5 -CGTCCGCCATCTTGGTAGAG-3 
5 -ATTCAATGTTCTCGGCATCGT-3 
Cd3g 5 -TGGAGAAGCAAAGAGACTGACA-3 
5 -GCCATCCACTTGTACCAAATTC-3 .
Cebpa C/EBPα 5 –CGGTCATTGTCACTGGTCAACT–3 
5 -GGACAAGAACAGCAACGAGTACC-3 
*(++) Only one intron
Cebpb C/EBPb 5 -GTTTCGGGACTTGATGCAATC-3 
5 -CGCAGGAACATCTTTAAGGTGAT-3 
Cebpd C/EBPd 5 -TCCACGACTCCTGCCATGTA-3 
5 -TGAAGAGGTCGGCGAAGAGTT-3 
Cebpg C/EBPg 5 -GCGCAGGTACATGTGAAGATT-3 
5 -CTGCGACAGCTTGCTCATT-3 
+ Cep170 KAB1 5 -GCCGAGCATCCTGATCACTT-3 
5 -AGAGAACTGAAAGACTGATGACAATAGC-3 
First thought to interact with
KRAB domains
+ Csf2ra1 GM-CSFRα 5 -CACCGCGTCCTGTAACTCTT-3 
5 -GCGCTCTGCCACTGGACCTCAAACT-3 
Data not shown; exp. declines
DN1-4
+ Ctbp1 5 -TGAGTCAGAGCCCTTCAGCTTT-3 
5 -CAATGGACGCCTGCTCACT-3 
*(−)
+ Cutl1 5 -CCATGGAAACTGTCTCTGTCTTCA-
5 -TGTCAGACTAGCTGGGTTGTTTG-3 
*(+)
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+ Dmtf1 Dimp 5 -ACACGGACGGGAATCTCATTC-3 
5 -AATGCTTTGATCATCCTCAGAGG-3 
*(+)
Dtx1 Deltex1 5 -GAGGATGTGGTTCGGAGGTA-3 
5 -CCCTCATAGCCAGATGCTGT-3 
*(−)
Elf4 MEF (myeloid Ets) 5 -CAGGCTCACCAAAACTGTGA-3 
5 -TTGGTCAGCACCGTAGTCAG-3 
+ Elk3 ERP 5 -CTGAGCAGAGCGCTGAGATAC-3
5 -TTCAGGATATCCGGGAAAGAG-3 
**(+)
+ Elk4 5 -GCTTTTCCAGTTTCCCTCTGT-3 
5 -TCTGCAGGTCTGGAGAAAATG-3 
+ Erg 5 -GCCTCCCAATATGACCACAA-3 
5 -TATTCTTTCACCGCCCACTC-3 
+ ESR1 Estrogen receptor 1 5 -GCTCCTGGACAGGAATCAAG-3 
5 -CTTCTCCCTGCAGGTTCATC-3 
Ets1 5 -AAAAGTGGATCTCGAGCTTTTCC-3 
5 -CTTTCAAGGCTTGGGACATCA-3 
Ets2 5 -GCAAGGCAAACCAGTTATTCCT-3 
5 -ACTTGTCAGAGAGTAGCTCCAGAAGAA-3 
+ Etv6 TEL 5 -TCCTGCTGCTGACCAAAGAG-3 
5 -CTGGCTTGGTGTGGATAGAG-3 
+ Fli-1 5 -ACAGACCAGTCCTCACGACTGA-3 
5 -CTTTTGTTGAGGCCAGAGTTCAT-3 
+ FoxJ3 5 -TGATCCCGGAAAGGGTTCTT-3 
5 -AGGCCCGTTCTACGGATCTT-3 
*(−)
+ Foxp1 5 –CTGGAAAACAGCCGAAAGAG–3 
5 –GGTTGGAGGGGAAGGGCAGG–3 
+ Foxp4 5 -CCCACAACCCTACCTTCTTCATC-3 
5 -GGGACCGGAGAACTAATTTTCA-3 
*(−)
Fus 5 -CAGCAACGAGCTGGAGACTG-3 
5 -TCTGGCTTAGGTGCCTTACACTG-3 
+ Gabpa 5 -TGCACTGGAAGGCTACAGAAAA-3 
5 -TTACCCAAACCACCCAATGC-3 
*(−)
Gapdh 5 -ACTCCACTCACGGCAAATTCA-3 
5 -GCCTCACCCCATTTGATGTT-3 
Gata2 5 -ACCACAAGATGAATGGACAGAA-3 
5 -GTCGTCTGACAATTTGCACAAC-3 
*(−)
Gata3 5 -GAGGTGGTGTCTGCATTCCAA-3 
5 -TTTCACAGCACTAGAGACCCTGTTA-3 
Called “Gata3-endog” in
Taghon et al., 2007
Gata3 (alternate) 5 -CCTGCGGACTCTACCATAAAA-3 
5 -GTGGTGGTGGTCTGACAGTTC-3 
In coding region; Taghon et al
2007
Gfi1 5 -AGCGTCGGAGAAGTCACTGT-3 
5 -CAGGTCAGACCCAGCAAGAC-3 
Gfi1b 5 -CCTTTGCCTGTGATGTCTGT-3 
5 -ATGAACGCTTGAAGGCTTTG-3 
+ Gse1 5 -GGGATTGAGGCAATCTTTGA-3 
5 -GGCTGAGGCTGTAGTTCTGC-3 
HEBAlt 5 -GTGCTTATCCTGTCCCTGGAATG-3 
5 -TGGCTTGGGAGATGGGTAAC-3 
Hes1 (Yun & Bevan) 5 -TACCCCAGCCAGTGTCAACA-3 
5 -TTCTTGCCCTTCGCCTCTT-3 
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Hes1 (alternate) 5 -CCAAGCTAGAGAAGGCAGACA-3 
5 -CGGTATTTCCCCAACACG-3 
Alternate primers, Yui &
E.V.R. 2004; data not shown
but similar
+ Hmga1 HMG-I(Y) 5 -AAAGTATCACCGGGTGGGTTTC-3 
5 -CATTAAAGTGGGTGGAGCCAAC-3 
+ Hprt 5 -GAGCTACTGTAATGATCAGTCA-3 
5 -ACCAGCAAGCTTGCAACCTT-3 
Id1 5 -GGCGAGATCAGTGCCTTG-3 
5 -AAGGGCTGGAGTCCATCTG-3 
**(+)
Id2 5 -GTCCTTGCAGGCATCTGAAT-3 
5 -CTCCTGGTGAAATGGCTGAT-3 
*(+) Possible detection of
genomic DNA?
Id3 5 -AGAGGAGCTTTTGCCACTGA-3 
5 -TGGAGAGAGGGTCCCAGAGT-3 
**(−)
Ikzf1 Ikaros 5 -TCCCAAGTTTCAGGAAAGGA-3 
5 -TCTGCTGTGCTCCAGAGGTA-3 
Ikzf2 Helios 5 -CACCTCAGGACCCATTCTGT-3 
5 -TGACAGCGTTCCTTGTGTTC-3 
Ikzf3 Aiolos 5 -CCGAGATGGGAAGTGAGAGA-3 
5 -CGCTTCTCACCGATGAATTT-3 
*(−)
+ Ikzf4 Eos; Zfpn1a4 5 -CCCAAACAGCCAACACTCTT-3 
5 -TTATCCAGGAGCCGTTCATC-3 
Il2rb IL-2/15Rβ 5 -ACGTCCATGCCAAGTCGAA-3 
5 -GGAACGACCCGAGGATCAG-3 
IL2-UP Il2 flanking seq. 5 -ACCTTGGGAGCTGAAATCCT-3 
5 -TTTTGAGGGATCGCTAATGG-3 
Detects genomic DNA; Adachi
& E.V.R., 2005
Il7ra IL-7Rα 5 -AGTCCGATCCATTCCCCATAA-3 
5 -ATTCTTGGGTTCTGGAGTTTCG-3 
*(−)
+ Jmjd3 5 -CCCTACCCCCAGCATCTATT-3 
5 -GCCTAAGTTGAGCCGAAGTG-3 
+ Klf13 5 -CGGGCTGCGAGAAAGTTTAC-3 
5 -GAGCGTGCGAACTTCTTGTT-3 
+ Klf15 5 -TTTTCCCGCTCAGATGAGTT-3 
5 -GCGATGCACTTTGATGTGTT-3 
*(+) No expression in
thymocytes
+ Klf2 5 -ATGCACCTGAGCCTGCTAGT-3 
5 -ATAGCACTGCCCTCTCCCTCT-3 
*(+) crosses tiny intron
Lat 5 -CTGTTGTCTCCTCTGCTCCTGT-3 
5 -CTCACTCTCAGGAACATTCACG-3 
Lck 5 -CTAGTCCGGCTTTATGCAGTG-3 
5 -CCGAGGGAGTCTTGAGAAAAT-3 
Lef1 5 -ACCTACAGCGACGAGCACTT-3 
5 -GGGTAGAAGGTGGGGATTTC-3 
+
+
Lima1 Eplin a: 5 -AGGAGAGCTGCGTGGAGTGT -3 
5 -GCAGTAGGAGCATCGGAAACAG-3 
b: 5 -AGGAGAGCTGCGTGGAGTGT-3 
5 -TGCAGTAGGAGCATCGGAAAC-3 
**(−)
*(−)
Mitf 5 -CCCCAAGTCAAATGATCCAG-3 
5 -CCTTAGCTCGTTGCTGTTCC-3 
Taghon et al., 2007
+ Mlf2 5 -ACCAGGAGACGTCGGAGATG-3 
5 -GCCCTATCCCGAATGTGATG-3 
MLL1 ALL-1 5 -TGCCCATAGCCCATCATCA-3 
5 -TCTGTGAATGAGGCCGATCTG-3 
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MLL2 5 -CCCGGTCCCGAATCAAAC-3 
5 -GAAGAGAACCACGGTATTTTGCAT-3 
+ Mta2 Mta1l1 5 -CTGAAGACCCCTACCCAACTTG-3 
5 -CCCGGTTAGCACTGGTTGTATAG-3 
+ Mta3 5 -CGTGCCGTGGGAACATTT-3 
5 -GTGTGTCCATGGCATGAAACA-3 
*(+)
Myb c-Myb 5 -GAGCAGAAGAAGTTTCCCGATTT-3 
5 -AGCGGGAATCGGATGAATCT-3 
Mybl2 B-myb 5 -AAGGAGGTGCTCCGTTCTGA-3 
5 -CCAGAGACTTGCGGACCTTCT-3 
+ Myst3 MOZ 5 -CCAGTGCTGAAGGGAAAGAG-3 
5 -ACAGATGGGGATTGGTTCAG-3 
*(+)
+ Nasp 5 -TGTAGCCGAACTGGCACTGA-3 
5 -TTCTACTGGCAATCATGGATACTGA-3 
+ Ncor1 5 -AATCTCATCCCCTATTAAACCAAACC-3 
5 -GTATATTACATGGAGTGCAAGAAACCA-3 
+ Ncor2 5 -CGCACACCGGATCCTAGAAG-3 
5 -TCCGCTTAAAGTACAAGATCAGCTT-3 
Nfe2 5 -TATGCAGCTTTTGGCAGAGA-3 
5 -GAGGGGCAGTGAAGACTGAA-3 
+ Pax1 5 -GGCAATGACCTTCAAACACC-3 
5 -CTGTGAGAGGACAGCCCCTA-3 
No expression in thymocytes
Pax5 5 -ACAGGACATGGAGGAGTGAATCA- 3 
5 -CCTTGATGGGCAAGTTCCACTA-3 
Anderson et al., 2004; no
expression in T
+ Per1 Period 5 -CCGAATACACACTTCGAAACCA-3 
5 -CGAAACACATCCCGTTTGC-3 
+ Pou2f1 Oct1 5 -AACCACCAACCTGCAACCA-3 
5 -TGCTGAGGTAGTTGCGTTAAAAGAT-3 
**(−)
+ Pou5f1 Oct4 5 -GGAAAGGTGTTCAGCCAGAC-3 
5 -CTCATTGTTGTCGGCTTCCT-3 
No expression in thymocytes
Pou6f1 Brn-5 5 -CTGCAACTCCCATCCCAATC-3 
5 -CGCAAACTCCCGGATCTCTTCT-3 
*(−)
Ptcra Pre-Tα, pTα 5 -CTGGCTCCACCCATCACACT-3 
5 -TGCCATTGCCAGCTGAGA-3 
+ Ptma Prothymosin α 5 -GGCGTGCCCCACCAT-3 
5 -CATTCTCTGCCTCCTCCACAAC-3 
+ Rara 5 -CTCCCAGGACCGCTTAACC-3 
5 -GGAGCTGCAAGTCCCAAGT-3 
+
+
Rbak 5 -TAAGTTGGAGCAGGGAGAAGAG-3 
5 -CAATTCCTTCTCTGGGGTCATA-3 
5 -TCGTCATGCTACACTGTGCACTAC-3 
5 -CCGGTGTGGACCCTTTGA-3 
Library-cloned new isoform
Conventional isoform
+ Rnf149 5 -GGAATTGATGTCGATGCTGA-3 
5 -GCCATGGGTCAATGCATATT-3 
+ Rreb1 5 -TCACCACCAATGGGAACATG-3 
5 -AACCGCCTGCGCTTCAG-3 
*(−)
Runx1 5 -CTCGGCAGAACTGAGAAATG-3 
5 -GGTGATGGTCAGAGTGA-3 
+ Runx2 5 -GCCTCCGCTGTTATGAAAAA-3 
5 -TGGGGAGGATTTGTGAAGAC-3 
*(+)
Runx3 5 -GGTTCAACGACCTTCGATTC-3 
5 -GGTCCATCCACAGTGACCTT-3 
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+ Saps1 mKIAA1115 5 -TTCATTGGCTCAACGAAGAGA-3 
5 -GGCTTAGGCGGATGATGTCA-3 
*(+)
Satb1 5 -CCACAAACACGGAGGTCTCT-3 
5 -GCAATCCCTGAGTTCGGTTA-3 
+ Sbf1 5 -AGGAGCTGCTGGATGTGATT-3 
5 -CCATGCTCAGAACATTGTGG-3 
*(+)
Sfpi1 PU.1 5 -CCCGGATGTGCTTCCCTTAT-3 
5 -TCCAAGCCATCAGCTTCTCC-3 
Sox4 5 -TCAAGGACAGCGACAAGATTC-3 
5 -GCCGGTACTTGTAGTCAGGGTA-3 
SpiB-1 SpiB, ex3-4 5 -CTGCAAGCCCTTCAGTTACC-3 
5 -AAAGGCAGCAGTAGCAGGAT-3 
See Dionne et al. 2005; David-
Fung et al 2006
SpiB-2 SpiB, ex1-2 5 -CTTGCTCTGGAGGCTGCAC-3 
5 -CCCCCATCTGAATCTGGGTA-3 
*(−); used in Yui &
Rothenberg, 2004
+ Stat5b 5 -GCTGTATCCGGCACATTCTGT-3 
5 -GTTTGGTTGATCTGAAGGTGCTT-3 
**(+) Serious titration anomaly
Tal1 SCL 5 -CTCACTAGGCAGTGGGTTCTTT-3 
5 -GGACCATCAGAAATCTCCATCT-3 
*(−)
+ Tbx21 T-bet 5 -AGGTGTCTGGGAAGCTGAGA-3 
5 -ATTCGCCGTCCTTGCTTAGT-3 
**(+)
Tcf12 HEB (canonical) 5 -GAGAAGAAGACCGCTCCATGAT-3 
5 -TGGCTTGGGAGATGGGTAAC-3 
Tcf7 TCF-1 5 -CAAGGCAGAGAAGGAGGCTAAG-3 
5 -GGCAGCGCTCTCCTTGAG-3 
Intra-exon: detects N-term half
of the HMG domain: “Tcf7.8”
Tcf7 (alt primers) TCF-1 5 -TGCTGTCTATATCCGCAGGAAG-3 
5 -CGATCTCTCTGGATTTTATTCTCT-3
*(+) Crosses from exon III to
IV: “Tcf7.3”; Taghon et al.,
2005
Tcfe2a E2A, Tcf3 5 -CAGATGGTGGCCTGGATACT-3 
5 -CATCCCTGCTGTAGCTGTCA-3 
+ Tfdp1 5 -GATAGGTGAATGGATCAGAGGTTAAGA-3 
5 -CCTTGGAACTGGAGTCACAGACTT-3 
**(−)
+ Thrap3 5 -GTTGTGCCGTTGCGAGAT-3 
5 -CTTGGGCGTGTACTTTGGAT-3 
**(+) Serious titration anomaly
+ Tle3 5 -TTGCGAAGAGACTGAACACAAT-3 
5 -GCGTTCAACTCCGTCATGGT-3 
Tox 5 -CCATGGACCTGCCAGAGATC-3 
5 -TTCTGCGTTCCCAATCTCTTG-3 
+ Trim25 Efp 5 -CGGAAAATTCGACACCATCT-3 
5 -CCTTGCAATTTTGCAGCTTT-3 
Trim44 5 -TCTGTGTCCTGTGTCCAGTCATT-3 
5 -CAGTCCACCGGAATCTTTGC-3 
+ Tsc22d1 5 -AAACGCTTCCGTGAGACTTG-3 
5 -TCACCGCATACATCAAATGG-3 
*(+)
+ Unk 5 -GTTGGGGCAGAGTACCTGAA-3 
5 -ACGTCCTGTTTGGGTTGAAG-3 
+ Yy1 5 -GCCAGAATGAAGCCAAGAAA-3 
5 -GGTGTGCAGATGCTTTCTCA-3 
+ Zbtb20 5 -CAGCCAAACAGAACTACGTCAA-3 
5 -TGCTACACTGGTACGCTCTCA-3 
**(−)
+ Zbtb48 5 -TGTCCCACATGTCACAAAAAGTT-3 
5 -TCTCCTTGCGGAAGTAACACTTC-3 
**(+)
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+ Zbtb7a LRF, Pokemon 5 -CCCTACGAGTGTAACATCTGTAAAGTTC-3 
5 -GTGGTTCTTCAGGTCGTAGTTGTG-3 
*(+) More sensitive due to
shorter amplicon than for
primers in Maeda et al. 2007
+ Zfp1 mKr1 5 -TGGAAGTGTGGAAGGCTGATG-3 
5 -TTTCTTCAGTTGGTGGTTGGTTC-3 
*(−)
Zfp109 5 -GCTGCTCAGAGGAAGCTGTA-3 
5 -CCCCAGTGAAAGGCATCTTA-3 
+ Zfp110 5 -ATGATGGAGAACTACAGCAACATGA-3 
5 -TGCATTGGCCAGCAGTCTT-3 
*(−)
+ Zfp238 5 -CGTCCTGTGATGAGAGTGATGT-3 
5 -TGGCTCATACTGTACCCTGTTG-3 
*(+)
+ Zfp28 mKr5 5 -TGTACTCAACATCGGAGACTTCACA-3 
5 -CTCCGTGACATCTACGATGACAG-3 
+ Zfp287 5 -CCCAAGAAGACTGGGAACTG-3 
5 -ACCATCCACGGCTCTTCTAA-3 
+ Zfp316 5 -CCCGGGTATCTCCCACTACT-3 
5 -TACACGGCCACATCTTCAAA-3 
+ Zfp358 5 -CATCGGGTCCTGTTCCAG-3 
5 -GGTCTCCATAAAGGGGCCTAA-3 
*(+)
+ Zfp382 KS1 5 -AAACCTGATATGATCCGCAAGT-3 
5 -TCACCAAAACTTCCTCCTCTTC-3 
+ Zfp384 CIZ 5 -GATTCCGCATGGTGAAGAGT-3 
5 -GTTACCGCTACCTGCTTCCA-3 
+ Zfp407 5 -TTCAGGGAGTCCTGCAGTTT-3 
5 -TGATGAACTGGGAGCCTTCT-3 
+ Zfp422 5 -CGAAGGGAATTCCGAGTTG-3 
5 -AAATACCCCCTTTGGGCTTT-3 
*(+)
+
+
Zfp426 5 -AAGCCAGACCTGAAATAAACCAGT-3 
5   -AGAGGCAATCTCCATTCCTCTTAA-3 
5 -TCCTAGTCTGACCCCCTGGTT-3 
5 -GCTTAGAGTCACATAGGTCCTCTTCA-3 
**(−); Known mRNA
*(−); Novel mRNA
+ Zfp598 5 -CAGGTGGTCTTTGGGAAGAA-3
5 -TGCAAACACCTTTCCATCTG-3 
+ Zfp748 2610014M12Rik 5 -ACACCCGCCACCAGTTC-3 
5 -TACAGCCCGGGGAGCAT-3 
+ Zfp771 DSC43 5 -GGGCAGCGAGGGGCACTT-3 
5 -CACTTGGGACTGGCACCTGAATTGTTCC-3 
Zfpm1 FOG-1 5 -GCCTCACTGAGGGCCTATCC-3 
5 -TCCTTAGCCAGCAGCTCTCATC-3 
+ Zkscan1 5 -CAGGGCTCTGAGAACAGGAATGG-3 
5 -CTGTTCCCGTTTCTCTCCAA-3 
+ Zkscan5 Zfp95 5 -CGTGGCTGTGATAGAGAGTATCCA-3 
5 -GTGGCTCCGGGTGGTACC-3 
**(−)
+ Zkscan21 Zipro 5 -CCGTCACTCTCCTGGAAGAC-3 
5 -GCCGTTCCTGAAGTTGACAT-3 
+ Zscan22 5 -CCGTTCTGGTGGAGGATATG-3 
5 -GGTGGCTCCAATTCATCTGT-3 
1
For original references to primer pairs that are not marked by “+”, see Anderson et al., 2002a, 2002b; Hernandez-Hoyos et al., 2003; Yui and Rothenberg,
2004; Anderson et al., 2004; Dionne et al., 2005; Taghon et al., 2005; Taghon et al., 2006; Franco et al., 2006; David-Fung et al., 2006; Tydell et al.,
2007; and Taghon et al., 2007.
2
Notations about titration curves: all slopes fall within the range of -3.0 to -3.7 ΔCT per tenfold dilution except as indicated:
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*
(−) slopes −2.6 to −2.99;
*
(+) slopes −3.71 to −4.1;
**
(−) slopes shallower than −2.6;
**
(+) slopes steeper than 4.1.
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TABLE 4
Expression patterns beyond the pro-T cell stages. (A) Definition of pattern types
for genes analyzed in the study. Genes were classified according to their patterns
of expression in the DN1-DN4 stages, based on their expression in cluster analyses
such as those in Fig. 4, with adjustment “by hand” to take into account whether
the dynamic ranges of their profiles exceeded the range of inter-experiment error,
or whether they were essentially flat in expression across these stages. Patterns are
described at the foot of Table 4A. Dynamic range indications are as follows: 10 =
greater than tenfold range from peak to trough in DN stages; 3 = between threefold
and tenfold range; 1 = less than threefold range. (B) Expression of genes in non-
T developmental contexts and in stages after β- or γδ-selection. Gene expression
levels were assayed in 2 samples each of the following: bone marrow derived pre-
myeloid cells; pro-B cells, as CD19+ cells from Rag2−/− mouse bone marrow;
Rag2−/− total thymocytes; TCRβ−/− total thymocytes; TCRγδ+ cells sorted from
TCRβ−/− thymus; and sorted subsets from wildtype thymocytes as follows: DN
(mostly DN3 & DN4); DP (CD4+ CD8+); CD4 SP (TCR+ CD4+ CD8−); and CD8
SP (TCR+ CD4−CD8+). Data from individual samples were first normalized
according to β-actin levels, then the geometric mean of independent samples was
calculated. To compare patterns of use for genes that are expressed at very different
levels, all values were then normalized to a reference “pan-DN” level for each
gene, that is the geometric mean of the values in Rag2−/−, TCRβ−/−, and sorted DN
wildtype thymocytes. The Table shows the resulting relative expression values.
For genes that increase in expression after β-selection, the sorted DN sample value
will be greater than 1; for genes that decrease in expression from the DN1 stage
through β-selection, the sorted DN sample value will be less than 1. Cells are
shaded to help discern different patterns of expression: orange shaded cells show
expression that is more than 3x higher than the reference pan-DN value; green
shaded cells show expression that is less than 30% of the level of the reference
pan-DN value; purple shaded cells show expression that is less than 1/10 of the
level of the reference pan-DN value. Gray shaded cells have no data.
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